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Cardiovascular disease (CVD) is the leading cause of death in men and women in 
the United States. Modifiable risk factors including obesity, physical inactivity and poor 
nutrition are suitable targets to reduce risk. Eggs are a source of high quality protein, 
vitamins, minerals, and antioxidants, yet consumption is still met with uncertainty. 
In order to examine the effect of consuming two eggs per day on certain 
biomarkers for CVD risk in a young, healthy population, we compared eggs to a heart-
healthy breakfast of oatmeal in an 11-week cross-over dietary intervention. Fifty 
participants were randomly assigned to consume either two eggs per day or one packet 
of oatmeal for breakfast for 4 weeks. After a 3-week washout period, participants were 
allocated to the alternate breakfast.  
Compared to oatmeal, there was no change in the LDL-C/HDL-C ratio, despite the 
increases in LDL and HDL cholesterol following egg intake. Modifications to dietary 
patterns occurred with a shift toward higher intake of protein and fat with eggs compared 
to an oatmeal breakfast. Participants self-reported feeling more satisfied after the egg 
breakfast, and in addition saw a decrease in plasma ghrelin, a biochemical marker of 
hunger.  
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Egg consumption had an impact on lipoprotein particle concentration, by resulting 
in an increase of large HDL and LDL. Large LDL is a less atherogenic lipoprotein than 
small LDL, while large HDL is postulated to be an indicator of more efficient reverse 
cholesterol transport. Additionally, consumption of eggs increased plasma lutein and 
zeaxanthin although dietary intake of these carotenoids was not different compared to the 
oatmeal period, suggesting increased presence in plasma with egg intake. Plasma 
choline was increased after egg intake, however, plasma trimethylamine N-oxide levels, 
a marker of CVD was not different between the egg and oatmeal periods.  
The consumption of two eggs per day as compared to an oatmeal breakfast altered 
dietary intake, increased satiety, and improved additional biomarkers of CVD risk, while 
no negative change was observed in LDL-C/HDL-C ratio or TMAO production. Based on 
these findings, habitual egg consumption does not increase risk of CVD and provides 
beneficial nutrients, antioxidants, and potential CVD protection.  
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Background 
Currently, cardiovascular disease (CVD) is the leading cause of death among adult 
men and women in the United States (1). CVD can be classified as a collection of 
disorders that arise from atherosclerosis, or the deposition of excess lipids into artery 
walls (2). Low-density lipoprotein (LDL) has the ability to migrate across the lumen and 
enter the arterial intima, where it can become oxidized (ox-LDL) (3).  When this occurs 
ox-LDL is taken up by macrophages leading to lipid accumulation and foam cell formation. 
The formation of macrophage foam cells is the hallmark stage of atherosclerotic lesions 
or “fatty streak” (2). As the uncontrolled uptake of ox-LDL continues, a plaque will form 
and increase in size with the addition of extracellular matrix macromolecules and the 
formation of a necrotic core. As this occurs, the fibrous plaque protecting the growing 
mass faces the risk of rupture and subsequent complications, such as myocardial 
infarction (4).  
The connection of ox-LDL to plaque formation has made cholesterol, both dietary 
and endogenous an area of concern when considering CVD risk. Since half of all U.S. 
adults have at least one of three risk factors that have been associated with the 
development of CVD, determining the risks associated with dietary cholesterol is of the 
upmost importance (5).  Over the last 20 years, research has vilified dietary cholesterol 
in a proposed connection with CVD risk. However, in this time, multiple research studies 
have found very little connection between dietary cholesterol and plasma cholesterol 
levels (6). A feedback loop has been identified, as cholesterol synthesis and clearance 
are controlled by two major transcription factors at the cellular level, sterol regulatory 
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element-binding protein-2	 (SREBP-2) and Liver X Receptor (LXR). These master 
transcription factors control expression of genes involved in cholesterol synthesis, 
transport, storage, and excretion, and are controlled by both dietary cholesterol intake 
and endogenous cholesterol levels (7). Systemically, the mechanism of reverse 
cholesterol transport (RCT) is involved in the removal and transport of cholesterol. The  
counter-balance of this regulatory system, is the scientific basis behind the 
acknowledgment of dietary cholesterol as a nutrient of non-concern (8). 
Furthermore, the 2015-2020 Dietary Guidelines for Americans (DGA) have 
removed the long standing daily intake limit of 300 mg/day of dietary cholesterol (9). This 
removal is based off numerous studies in various populations, with results concluding 
dietary cholesterol is considered “not a nutrient of concern” (9). However, despite this 
development, foods high in dietary cholesterol are still advised to be consumed with 
caution. Eggs have become a focus of dietary cholesterol intake, as they are a natural 
source of approximately 180 mg of cholesterol per egg (10). Currently, the American 
Heart Association (AHA) is providing information to individuals with heart disease that all 
the cholesterol is found in the yolk, and egg whites without the yolk are a heart healthy 
source of protein (11). There is no distinction from AHA recommendations between 
dietary and endogenous cholesterol, thus confusion surrounding the safety of the 
consumption of eggs and other foods high in dietary cholesterol is common.  
This issue has been challenged by numerous studies in our laboratory 
demonstrating the lack of increased risk factors of CVD with dietary cholesterol 
consumption and additional beneficial effect of daily whole egg consumption (12–14). 
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Whole egg consumption studies have resulted in lack of increase in CVD risk and 
improved markers of chronic inflammation, glucose intolerance, and insulin resistance in 
several distinct populations including children (15), individuals with metabolic syndrome 
(16) and type 2 diabetes (17).  
Nutritionally, eggs are one of the highest quality protein available in a single food 
source and also contain essential vitamins & minerals, antioxidants lutein and zeaxanthin, 
lecithin, choline, cholesterol and phospholipids (PL) (18,19). Previous studies have 
associated habitual egg consumption with decreased energy intake, increased satiety, 
and weight loss in certain populations (20,21). High quality protein or complete protein 
contains all indispensable and dispensable amino acids and are easily digestible (19). 
Protein can increase satiety or the feeling of fullness, as well as increase energy 
expenditure (22).  
Beyond the nutritional benefits, egg consumption has been shown to increase 
high-density lipoprotein (HDL) particles, which is the major lipoprotein involved in reverse 
cholesterol transport (RCT) and CVD protection (18). Classical RCT “includes the efflux 
of cholesterol from peripheral tissues to the liver mediated mainly by HDL particles, and 
the subsequent secretion of this cholesterol by the liver in bile that is transported to the 
intestinal lumen, leading to fecal excretion of cholesterol” (23). Thus, increased circulation 
of HDL cholesterol (HDL-C) has been suggested to be a biomarker of increased RCT and 
have the ability to reduce atherosclerotic development (24). Studies have shown the 
ability of eggs to increase HDL concentration in circulation, which may improve RCT, by 
the proposed ability to carry more cholesterol to the liver for excretion (14,17,25). PL have 
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been suggested to play a role in the ability of HDL to accept excess cholesterol from cells 
during the early stages of RCT (26). Specifically, PL from eggs, have been observed to 
be preferentially incorporated into HDL particles and to have a potential role in the 
beneficial remodeling of HDL (27,28). Additionally, whole egg consumption has been 
associated with the upregulation of genes associated with RCT, such as cholesterol efflux 
transporters, ATP-binding cassette transporter A1 (ABCA1) and ATP-binding cassette 
transporter G1 (ABCG1). The HDL receptor, Scavenger Receptor class B type 1 (SR-BI), 
which clears HDL from circulation through selective CE uptake, expression has been 
shown to be upregulated in hepatocytes during efficient RCT, which may suggest 
increased hepatic clearance as cholesterol by HDL may be to targeted for biliary excretion 
(29).  
Despite the promising research regarding eggs and benefits both nutritionally and 
beyond, habitual consumption is still met with uncertainty. The purpose of this study is to 
investigate eggs consumed at breakfast as compared to oatmeal, another commonly 
consumed breakfast food. The basis of the study is to compare the two foods as equally 
valuable and healthy choices for a healthy breakfast.  
For the purpose of the dietary intervention, whole eggs are compared to oatmeal, 
which is an American Heart Association “certified heart healthy food.” The main benefit 
of oatmeal is the ability to lower low-density lipoprotein cholesterol (LDL-C), presumably 
via the soluble fiber content of the product (30). Oatmeal is also a good source of B 
vitamins, iron, magnesium, and selenium. The two foods were selected for the 
intervention as cost comparative, readily available and calorically matched. 
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This was the first study, to our knowledge to compare the consumption of a heart 
healthy breakfast of oatmeal to two eggs per day in a breakfast time, cross over 
intervention. The main objective of this dissertation is to investigate the effects of two 
different breakfasts on lipoprotein metabolism, appetite regulation, and additional 
biomarkers of CVD risk. We believe the consumption of two eggs per day for breakfast, 
will not negatively impact biomarkers of CVD risk, while proving a viable option for 
nutrition, satiety, and additional health benefits. 
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Research Questions 
Central Hypothesis: We hypothesized that consumption of two eggs per day as 
compared to one packet of oatmeal for breakfast will not negatively impact plasma lipids 
or biomarkers of lipid metabolism but will alter dietary composition patterns associated 
with increase perceived satiety and decreased hunger. Additionally, compared to 
oatmeal, eggs may provide additional benefits to HDL metabolism through lipoprotein 
remodeling and modifications in the expression of genes associated with lipid metabolism 
and oxidation, while increasing presence of plasma carotenoids.  
Question 1: Will the consumption of two eggs per day as compared to an oatmeal 
breakfast maintain or improve plasma lipid and apolipoprotein profiles and lipid transfer 
proteins, LCAT and CETP, while not increasing risk of CVD in a young, healthy 
population?  
Hypothesis 1: We hypothesized the consumption of two eggs per day would not 
negatively alter the LDL/HDL ratio, a well-accepted predictor of CVD risk. We further 
hypothesized that TC, LDL-C and HDL-C would increase following the consumption of 
eggs, which would further support the first part of the hypothesis. We expected favorable 
alterations of apolipoprotein profiles and increase in lipid transfer proteins associated with 
reverse cholesterol transport. 
Question 2: Does the daily consumption of two eggs as compared to an oatmeal 
breakfast have influence on dietary composition patterns of macronutrient, micronutrient, 
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and phytochemical intake? Will the change in dietary composition have an impact on 
appetite regulation as reported by objective and subjective measures? 
Hypothesis 2: We hypothesized the increased protein from egg consumption would alter 
dietary intake patterns, which would have an impact on appetite. As assessed by 
subjective and objective measures, we predicted that following the consumption of 2 eggs 
per day as compared to oatmeal hunger would be decreased. 
Question 3: Will the consumption of two eggs per day have an effect on plasma 
concentration of lipoprotein particles, presence of egg-associated plasma carotenoids, 
and Trimethylamine N-oxide (TMAO) production?  Additionally, will any effect of egg 
consumption be reflected in changes in gene expression associated with cholesterol and 
lipid metabolism and TMAO production, as assessed in peripheral mononuclear blood 
cells (PBMC)? 
Hypothesis 3: We hypothesized that consuming two eggs per day for breakfast would 
result in benefits beyond nutrition, through increased HDL particle concentration, 
increased presence of egg-associated antioxidants in plasma. We expect to find no 
increases in TMAO production, based on the assumption that choline from eggs will not 
increase production of the metabolite TMA. We further hypothesized decreased gene 
expression of cholesterol synthesis associated genes with no changes on TMAO related 
genes. 
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Section 1 
 
Dietary Cholesterol 
 
 
 
 
Introduction 
Over the last 50 years, eggs have been a single food surrounded by controversy. 
In 1968 the AHA chose to relate a particular food, eggs, to the development of CVD, and 
a prevention tactic for the general public (1). The recommendation of no more than three 
egg yolks per week was based on epidemiological studies, animal studies fed 
pharmacological levels of dietary cholesterol as well as misunderstood and incomplete 
data (2). Regardless, the affordable, convenient, high protein and nutrient – rich animal 
product, the chicken egg, was targeted as the icon for dietary cholesterol.  
 
Early Research  
Based on a series of epidemiological studies at the time, data was indicating a 
relationship between dietary cholesterol intake and risk of CVD (3,4). The Seven 
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Countries Study (1958-1964), found a relationship between saturated fatty acids, trans 
fatty acids and dietary cholesterol intake to 25-year death rates from coronary heart 
disease (CHD). However, the data at the time, cited limitations such as the varying diets 
among countries involved and the inability to combine all the data for one conclusion. 
Additionally, prevalence of smoking was not considered, and authors state the cessation 
of smoking is the corner stone of CVD prevention (3). Although, several other studies 
were challenging the results, data from the Framingham study (1984-1988) reported 
dietary cholesterol was not a predictor of plasma total cholesterol (TC) or LDL-C, in a 
population of ~3,800 women. Authors concluded the need for public policy and food 
industry modifications, to change the health messages and claims related to dietary 
cholesterol. A relationship between saturated fat and an increase in TC and LDL-C was 
significant, in this population, and authors warranted awareness of saturated fat content 
in food (5). Dietary interventions of cholesterol feeding were being carried out through this 
period as well. A cross-over study using 50 males, aged 46-47 years, consumed a low to 
high cholesterol diet for 6 weeks each. During the 6 weeks of high cholesterol diet, 
participants consumed 3 large eggs a day. Participants were also assigned and 
counseled to consume one type of dietary fat, either saturated fatty acids (SFA) or 
polyunsaturated fatty acids (PUFA), comprising 35% of total calories. The purpose of this 
intervention was to assess dietary fat quality and cholesterol quantity. Results showed 
subjects compensated for high cholesterol intake by decreasing endogenous cholesterol 
synthesis and/or cholesterol absorption. The conclusion of this study found plasma 
cholesterol levels were more sensitive to dietary fat quality than cholesterol quantity (6). 
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Despite these results, dietary guidelines and AHA still stated a daily intake limit of 
300 mg/day. This put the consumption of one egg, with ~180 mg of cholesterol at the top 
of the “consume with caution” list. With a drastic reduction in the consumption of eggs, 
the industry had much research to do, thus the mechanistic relationship between dietary 
and plasma cholesterol became an area of focus and research. 
Metabolism of Dietary Cholesterol 
Cholesterol is a four-ring core structure with a hydroxyl group and hydrocarbon 
chain. The structure of this molecule allows it to be an important part of cellular 
membranes. The ability to modify membrane fluidity begins with the polar hydroxyl group, 
which has the ability to interact with membrane PL, while the nonpolar hydrocarbon chain, 
can stay bound to the membrane (7). Approximately 1 gram of cholesterol is synthesized 
in animal tissue per day, while ~400 mg of cholesterol is taken through the diet (8). The 
turnover of cholesterol can be modeled using 3 exchangeable pools: pool 1 accumulating 
quickly in the plasma, blood cells, liver and intestines; pool 2 forming at an intermediate 
rate in the visceral and peripheral tissues; and pool 3 forming slowly in the adipose, 
connective and skeletal tissues, muscles and arteries (9).  In addition to its importance of 
cholesterol for cell membrane function and structure, cholesterol also is a precursor to 
bile acids, steroid hormones, oxysterols, and vitamin D, which all play roles in cellular 
homeostasis (10).  
The intricate mechanism of cholesterol metabolism has been steadily elucidated 
over the years, with the conclusion resulting in a biosynthetic feedback loop under 
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physiological control. In short, as more dietary cholesterol is consumed from the diet 
(exogenous), cholesterol production and uptake within cells (endogenous) is 
subsequently down regulated. This loop is under control of two master transcription 
factors, LXR and SREBP-2, which control numerous transporters, transfer proteins, 
lipoprotein particles and exchangeable apolipoproteins involved in the cholesterol 
metabolism.  
Dietary cholesterol is consumed and packaged into mixed micelles to cross the 
brush border membrane of the small intestine via Niemann-Pick C1-Like 1 (NPC1L1), or 
other transporters such as Cluster determinant 36 (CD36), SR-BI, or ATP binding 
cassette family members (11). Some free cholesterol along with most plant sterols can 
be effluxed back into the intestine by a heterodimer of ATP-binding cassette subfamily G 
member 5 (ABCG5) and ATP-binding cassette subfamily G member 8 (ABCG8) for 
excretion. Cholesterol can be effluxed to apolipoprotein AI (apo-AI), to form nascent HDL, 
the main lipoprotein involved in RCT, via the action of ABCA1 or packaged by microsomal 
triglyceride transfer protein (MTP), along with cholesteryl esters (CE), PL and triglycerides 
(TG) into chylomicrons (CM) with apoB-48. CM are exocytosed into the lymphatic system 
for circulation and delivery of contents to tissues (8,12,13). The circulation of CM will 
deliver cholesterol to the tissues, and may also return some cholesterol to the liver, where 
it can be repackaged and recirculate as part of very-low-density lipoprotein (VLDL) (14). 
VLDL will transform to LDL as TG are delivered to tissues, then LDL, which is the main 
lipoprotein responsible for delivering cholesterol to tissues, will do so, thus increasing 
cellular cholesterol levels (8).  
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As this is occurring the body may enter a state of excess cholesterol, ABCA1, 
ABCG1 and ABCG5/8 are transcribed to produce a mechanism of cholesterol disposal 
(15). ABCA1 and ABCG1 have direct roles in reverse cholesterol transport and the ability 
to efflux cholesterol to HDL through binding of apoA-1 (16). These transporters are also 
important for the formation of HDL particles and removal of excess cholesterol. ABCA1 
will efflux cholesterol to nascent HDL, through the binding of apoA-I to ABCA1 and 
utilizing phospholipids, free cholesterol (FC) is transferred to the nascent HDL particle. In 
plasma, lecithin:cholesterol acyltransferase (LCAT) can esterify FC to CE and deliver CE 
to the core of the HDL particle, causing the particle to enlarge. Then, ABCG1 is able to 
interact with larger HDL particles and efflux FC to be converted to CE and increase the 
size of HDL (17). Cholesterol returned to the liver from CMR, LDL or HDL destined for 
excretion can be hydrolyzed to FC and secreted directly into the bile. Cholesterol can also 
be converted into bile acids utilizing the rate-limiting enzyme cholesterol 7 alpha-
hydroxylase (CYP7a1)(18). This process is upregulated in the presence of excess 
cholesterol and oxysterols via LXR and several other nuclear receptor interactions that 
will increase bile acid production and decrease bile acid reabsorption, decreasing cellular 
cholesterol levels (19). Signaling cascades suspected to be involved in cholesterol efflux 
are cyclic AMP (cAMP) as a second messenger to protein kinase A (PKA), with 
involvement in ABCA1 messenger RNA (mRNA), cholesterol efflux and ABCA1/G1 
phosphorylation. Other signaling cascades such as protein kinase C (PKC) and janus 
kinase 2 (JAK2) have been proposed by several studies to have stimulation on mRNA, 
phosphorylation, or efflux related to ABCA1 (20). 
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Clinical Studies   
 In a large scale, meta-analysis, 27 studies were evaluated to determine the effects 
of dietary cholesterol on serum cholesterol. Studies involved in the analysis had varying 
amounts of dietary cholesterol, from 10 to 4800 mg/day coming from various sources. 
Results reported a modest amount of cholesterol added to the diet would reflect little 
change in serum cholesterol levels. Individual variability was found to be a noted feature 
of this analysis, citing about 50% of the population variance could be contributed to 
genetic factors (21). This finding has been confirmed when examining homogenous 
compared to heterogeneous populations (22). Another systematic review and meta-
analysis that utilized data from forty studies, with a total of 361,923 subjects reported a 
conclusion was unable to be drawn regarding the effects of dietary cholesterol on CVD 
risk. This analysis did not consider LDL and HDL subparticles, although authors 
acknowledged dietary cholesterol and the developing association with large size particles; 
and cite the lack of inclusion as a limitation to this study. For the studies included that 
found potential risk of dietary cholesterol with CVD risk, confounders such as increase 
consumption of SFA and percentage of calories from fat, decreased vegetable and fiber 
intake, and flaws in study design are explained by the authors (23). Rong et al found up 
to one egg a day does not pose an increased risk of CHD or stroke (24). However the 
effect of egg consumption in a diabetic population is still misunderstood (25–27). Despite 
the 20 years between the two meta-analyses presented, there is still uncertainty 
surrounding the regular feeding of dietary cholesterol, which in the daily American diet is 
mostly supplied through the consumption of eggs.    
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Considerations 
Hypo- and Hyperresponders 
 As noted above, genetic variation is an important determination of dietary 
cholesterol influence on serum values. It has been identified that persons can be 
classified as hypo- or hyperresponders to dietary cholesterol. A study investigating a 
normolipidemic male (n=40) population given dietary cholesterol in the form of 3 whole 
eggs/day (~640 mg chol/day) found 15 hyper- and 25 hyporesponders. Definition of 
hyporesponders is an increase in plasma TC of < 0.05 mmol/L or hyperresponders, 
increase in TC of ³ 0.06 mmol/L for each additional 100 mg of dietary cholesterol 
consumed, for the purpose of this population. Hyporespoders had no change in LDL-C, 
HDL-C or LDL/HDL ratio, while hyperresponders (37.5% of the population) had significant 
increases in both LDL-C and HDL-C and activities of LCAT and CETP. Findings suggest 
that while hyporesponders are not effected by added dietary cholesterol, 
hyperresponders cholesterol metabolism and RCT is enhanced. Although authors did 
note a concern, that hyperresponders LDL/HDL ratio was significantly increased (28).  
 
Previous Dietary Patterns 
An area of consideration is the previous diet of participants involved in a dietary 
cholesterol feeding trial. It has been noted that participants who consume a low 
cholesterol diet at baseline may have an increased response to added cholesterol (29). 
For example, lactovegetarians who were fed 3 eggs yolks per day had increased 
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cholesterol absorption and serum concentrations of both TC and LDL-C (30). Additionally, 
the Tarahumara Indians of Mexico who typically consume a diet very low in cholesterol, 
due to minimal consumption of eggs and chicken, were followed. This population has a 
naturally “antianthogenic” diet as defined by authors, and when fed a western diet for 5 
weeks, plasma cholesterol increased 31%, with the majority in LDL fraction, although a 
small increase in HDL was observed, and LDL/HDL ratio increased slightly (31). What is 
unique of this population, is the genetic homogeneity, which may have attributed to the 
dramatic changes in lipid profile (21,31,32).  
Apolipoprotein Profile and Lipoprotein Subspecies 
 Alterations to apolipoprotein profile and modification of lipoprotein particle 
subspecies are another consideration when evaluating the role of dietary cholesterol. The 
study by Herron et al. reported a shift to LDL particle pattern B in hyperresponders, 
trending toward larger, less atherogenic sized particle, a suggested compensatory 
mechanism for added dietary cholesterol in certain populations (33). Lipoprotein particles, 
have the ability to be re-modeled in circulation forming various subspecies. The variation 
in subspecies has been hypothesized to affect both function of the lipoprotein in 
circulation and ability to become oxidized, leading to incorporation into an atherosclerotic 
plaque (34). Apolipoprotein E (apo E) is a circulating protein that can be found on CM, 
VLDL, intermediate-density lipoproteins (IDL), and HDL. It has various roles in lipid 
metabolism, and is necessary for apo E specific receptor uptake of LDL to LDL receptor 
(LDL-R) (35). Variations in apo E concentration and genetic alleles have been shown to 
have a relationship to how a particular genetic group responds to dietary cholesterol and 
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subsequent plasma cholesterol values. Depending on the allele combination an individual 
can have a reduced binding affinity (and thus clearance) of LDL receptors to LDL 
particles. Or conversely, can have an increased rate of clearance from plasma, depending 
on the allele or polymorphism (22). The retention or removal of LDL from circulation is 
critical in the development of CVD, as the more efficient the clearance of LDL from 
circulation is, the less chance the particle has to become oxidized (20).  
This may be associated with the genetic compensation mechanism discussed 
above, along with the effect of dietary cholesterol delivered specifically by eggs. The 
second phenomenon, being the components of eggs, as opposed to other sources of 
dietary cholesterol may provide additional benefit. This will be described in more detail 
thought out the literature review.    
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Implications of Dietary Cholesterol from Eggs 
Overwhelming evidence throughout the past 50 years has supported the notion 
that dietary cholesterol may have a minimal impact on plasma cholesterol, because of its 
known effect in increasing both LDL-C and HDL-C and maintaining LDL-C/HDL-C ratio. 
Thus, cellular cholesterol biosynthetic pathway is an effective mechanism by which the 
intake of dietary cholesterol is well regulated as it will be reduced with increased dietary 
cholesterol. Based on this finding the 2015-2020 DGA have removed the previous daily 
dietary cholesterol intake level of 300 mg/day, and have listed it as “not a nutrient of 
concern (36).” Still, the habitual consumption of eggs is still met with hesitation. 
Throughout this literature review, the numerous potential benefits of eggs will be 
discussed.  
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Section 2 
 
Eggs and HDL 
 
 
Introduction 
Dietary intake has been shown to have an influence on lipoprotein concentration, 
composition and metabolism. Dietary interventions utilizing eggs as the source of dietary 
cholesterol have had mixed results in TC, LDL-C and HDL-C values. The variation in 
these results may be attributed to many factors such as age, gender, hormonal status, 
obesity and genetic variation (37). However, an increase in HDL-C is a major finding in 
most studies with egg feeding. The proposed mechanism is a response to dietary PL 
provided by eggs, which may enhance RCT, as a necessary component of HDL 
formation, and as a compensatory response to effectively return any excess cholesterol 
from the tissues to the liver for excretion. Eggs have many components beyond dietary 
cholesterol which make them unique to enhance RCT. The increased dietary cholesterol 
is thought to initiate the formation of HDL particles and collection of cholesterol from the 
tissue (38). Eggs are a naturally rich source of protein, fat, vitamins, minerals, and 
carotenoids, lutein and zeaxanthin. PL also appear to have a role in RCT, which makes 
eggs a candidate for providing benefits beyond nutrition, including changes in HDL 
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metabolism, cellular health and the presence of the antioxidant carotenoids, lutein and 
zeaxanthin.  
HDL Metabolism: Reverse Cholesterol Transport 
Lipid Accumulation and Maturation 
RCT begins with the synthesis of apoA-I, which is essential for the formation of 
HDL. ApoA-I is synthesized in both the liver and intestine and is transcribed from the 
APOA1 gene (38). When a ligand is bound to peroxisome proliferator-activated receptors 
(PPAR) a heterodimer complex is formed with retinoid X receptor (RXR). This complex 
binds to peroxisome proliferator response elements (PPRE) to regulate the transcription 
of APOA1 gene (39,40). The first step in HDL-mediated RCT is the formation of nascent 
discoidal particles followed by the formation of mature round HDL particles. Lipid-poor 
apoA-I interacts with cellular membranes to acquire PL and FC. ABCA1 is the proposed 
transporter of FC and PL to lipid-poor apoA-I, and is found on plasma membranes of 
tissues and macrophages and is critical for initial lipidation of nascent HDL, especially at 
the liver and intestine (41,42). ApoA-I is amphipathic and interacts with ABCA1 to allow 
the movement of the non-polar cholesterol to non-polar PL tails.  Although, the detailed 
mechanism of FC and PL transfer to apoA-I and interaction with the plasma membrane 
during the formation of nascent discoidal or lipid-bound HDL is not well understood (43). 
Initial lipidation of HDL is thought to occur at the liver and intestine, but most of HDL mass 
is derived from other tissues and other lipoproteins (44). As nascent HDL circulates to 
peripheral tissues it joins the phospholipid bilayer with the C terminus of apoA-I by 
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incorporating the protein into the membrane of the particle to collect FC (45). The 
discoidal particle then binds to ABCA1 using apoA-I as the ligand to transfer FC to HDL, 
as previously described. In plasma, LCAT, an HDL associated enzyme will esterify FC to 
form CE that will travel to the core of the molecule, and cause an increase in particle size 
(45).  LCAT is critical for the formation of CE, as well as catalyzing the transfer of fatty 
acids from PL to FC. As collection of FC and PL occurs, the particle increases in size by 
acquiring contents via ABCA1, and additionally through ABCG1, rendering the HDL 
particle mature (17).  
Alternative pathway  
An additional interaction in the RCT process occurs between HDL and apoB 
containing lipoproteins CM, VLDL, and LDL through cholesterol ester transfer protein 
(CETP). This interaction exchanges TG from apoB containing lipoproteins for CE found 
in the core of HDL (46). CETP deficiency in humans results in extremely high levels of 
HDL-C, with large HDL and slowed turn-over of apoA-I (47). Through this interaction, HDL 
becomes CE depleted and TG rich. HDL can also acquire PL from apoB containing 
lipoproteins via the phospholipid transfer protein (PLTP), which is bound to HDL. As TG 
rich lipoproteins circulate and hydrolysis of TGs occurs, the particle becomes smaller in 
size and loses surface PLs, which HDL then can pick up using PLTP (48). The transfer 
of PL to HDL results in the formation of the larger mature HDL particle size and pre-b HDL 
particles. 
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Catabolism 
SR-BI is thought to be the main regulator of hepatic HDL-C uptake. SR-BI is 
thought to act by selective uptake. In the liver, it is proposed that SR-BI mediates uptake 
of whole HDL particles, removes cholesterol and then can release small cholesterol-poor 
HDL particles back into circulation (49,50). Overexpression of SR-BI in mouse livers 
reported significantly increased HDL-C uptake and reduced plasma HDL-C levels (51). 
Cholesterol carried in HDL can also return to the liver after it has been transferred to an 
apoB containing lipoprotein via CETP, by utilizing the LDL-receptor. Once cholesterol is 
returned to the liver, it can be targeted for excretion in the bile and feces. HDL and apoA-
I can be degraded by lysosomes in the liver and kidney. Lipid-poor apoA-I has been 
shown to be filtered by the glomerulus and catabolized by the cubilin/megalin system (52).  
Plasma HDL 
Studies in various populations, including children, healthy and obese men and 
women have shown either unchanged on increased HDL-C following the consumption of 
at least one egg per day for a minimum of four weeks (53). An increase of HDL-C by 1 
mg/dL suggests between a 2-3% reduction in CVD risk, as reported by cross-sectional or 
population-based studies (54). Therefore, the consumption of eggs providing an increase 
in HDL-C with an unchanged LDL/HDL ratio may provide benefit in prevention of CVD 
development. A study where overweight/obese adult males were consuming three 
egg/day with a carbohydrate restricted diet (CRD), as compared to a CRD control group, 
increased plasma HDL-C, while LDL-C was not changed. Authors attribute the increase 
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in HDL-C to added dietary cholesterol, which did not impact weight loss in this population, 
and decreased the LDL/HDL ratio (55). A study in children found the consumption of two 
eggs per day increases both HDL-C and LDL-C, with no change in LDL/HDL ratio. The 
increase is attributed to the increase in dietary cholesterol from egg consumption (56). In 
a Metabolic Syndrome (MetS) population, the consumption of 3 eggs per day while 
following a CRD increased plasma HDL-C (57). The impact of HDL-C levels in the 
previously mentioned studies has been hypothesized to have a positive relationship with 
lipoprotein particle size, and ability to carry antioxidant carotenoids, which are key factors 
when evaluating risk of CVD. 
Lipoprotein Particle Size 
Based on the knowledge that HDL particles are diverse in composition and size, it 
is crucial to examine the ability of each species to have varying anti-atherogenic effects. 
There are many ways to separate HDL particles utilizing techniques such as: Nuclear 
Magnetic Resonance (NMR), ultracentrifugation and fast protein liquid chromatography 
(FPLC) to determine particle subfraction, size and distribution. HDL particles can be found 
between d = 1.063–1.21 g/mL, and this density will vary due to lipid and protein content 
(58). Data has reported that based on the varying separation techniques that both large 
and small HDL have inverse relationships to CVD risk (59). The components and 
functions of HDL species will be evaluated in regards to the ability to be anti-atherogenic 
and have beneficial roles in RCT.  
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HDL remodeling 
Mature HDL can be remodeled into smaller HDL particles and subsequently 
release lipid-poor apoA-I (60). During remodeling CE are removed from HDL via CETP 
and PL and TG can be hydrolyzed (44).  Additionally, HDL can be modified by lipolytic 
enzymes hepatic lipase (HL) and endothelial lipase (EL). HL can hydrolyze TG and PL in 
HDL, and is thought to be most efficient when HDL is TG enriched (60). When HL 
hydrolyzes TG from HDL, the particle size is reduced and apoA-I may be released. EL, 
while similar to HL, has been described to have more phospholipase activity and a greater 
preference for HDL over apoB containing lipoproteins (61). Plasma EL levels in humans 
have a strong inverse relationship to HDL-C (62). 
Effects of Eggs  
Further analysis of Mutungi et al. (55) identified increased number of large HDL 
particles in participants consuming 3 eggs per day with a CRD. A subsequent increase in 
LCAT activity was cited to have a relationship to the increased HDL size in association 
with egg consumption. Although, no changes in apoA-I and the total number of HDL 
particles was found, a reduction in apoA-II was identified. ApoA-II is often associated with 
medium HDL particles, thus proposing an explanation to the effect (63). Additional 
analysis from Blesso et al. (64) observed improvements in HDL particle size and number 
following the consumption of eggs. The increase in large HDL number and size was 
correlated with plasma HDL-C, and may reflect a shift to a more anti-atherogenic lipid 
profile. Results reported a reduction in apoA-II and medium HDL, and increased activity 
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of LCAT, which may be indicators of enhance capacity of HDL maturation and possible 
explication for HDL remodeling following egg consumption. Finally, a study in a young, 
healthy population that consumed one, two and three eggs over the course of 14 weeks 
found an increase in large HDL particle concentration, with an increase in LCAT activity. 
Authors concluded increased esterification of FC by LCAT, which is needed for effective 
RCT and enhancement of HDL composition and function (65).  
Carotenoids 
HDL is also known to carry the carotenoids lutein and zeaxanthin, which possess 
antioxidant properties (66). Both of these carotenoids are hypothesized to be part of the 
mechanism of how HDL has antioxidative effects on LDL, PL and other tissues by 
preventing oxidation and protecting tissues from oxidative stress. Studies have shown 
relationships between the carotenoids and upregulation of ABCA1 and promotion of 
cholesterol efflux (67). Lutein and zeaxanthin are distributed to most tissues, but are 
found concentrated in the eye, and have shown to be important to the prevention of age 
related macular degeneration (68). Lutein is at least 20 times more potent than vitamin E 
in preventing PL oxidation, therefore, the large HDL with the ability to carry more 
carotenoids may be the most relevant in preventing LDL oxidation and contributing to 
RCT (69).  As mentioned, large HDL is proposed to carry more lutein and zeaxanthin in 
circulation. 
Lutein has a higher concentration in plasma (63). In another study, post-
menopausal woman consumed either 3 eggs per day or abstained from eggs for 3 weeks, 
in a 30-day crossover. An increase in LDL and HDL size was associated with circulating 
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plasma lutein, attributed to egg consumption. It was shown that larger LDL and HDL 
particles carried more lutein, though the proposed ability of the carotenoids to associate 
with the surface layer of the lipoproteins. Since large LDL and HDL have more surface 
area, there is a proposed increased area for carotenoid incorporation (70).  It is suggested 
that assuming the distribution of lutein to be 10% VLDL, 46% LDL, and 44% HDL, which 
was calculated to the number of lutein molecules per lipoprotein to be ~2 lutein 
molecules/VLDL particle, 3 lutein molecules/10 LDL particles, and 7 lutein 
molecules/1000 HDL particles (70). This relates the increase in HDL size, as opposed to 
number has a relationship with carotenoid transport. 
Phospholipids 
In a feeding study utilizing a MetS population, 3 eggs/day were consumed over 12 
weeks. Results indicated an increase in HDL-C, large HDL particle number, large HDL 
and LDL diameters, and LCAT activity (71). These results could be indicative of an 
increase in RCT and benefit of HDL metabolism. To further investigate the impact of 3 
eggs per day, cholesterol efflux to subject serum was measured in Raw 246.7 
macrophages. Results showed cholesterol efflux was significantly increased in the egg 
consumption group. The proposed cause of the increased efflux due to egg consumption 
is the large presence of PL which are incorporated into HDL (71). Yolk is one of the richest 
sources of highly bioavailable PL, which is thought to be preferentially incorporated into 
HDL (72). A proposed influence from whole egg consumption on RCT has been 
described, with eggs influencing the lipid-accepting capacity of HDL, and imperative step 
of RCT. PL are a class of bioactive lipids that have proposed roles in inflammation, 
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cholesterol metabolism and HDL function (73). Although, eggs are one of the richest 
sources of PL in the diet, not much research has examined egg-specific PL and their role 
in reduction of CVD risk. Recently, a relationship between PL and increased HDL-C has 
been seen in human and animal studies (74). The proposed mechanism is the preferential 
incorporation of dietary PC into HDL particles. It has been suspected that PL are 
transferred to HDL from CM in circulation or by direct secretion in HDL derived in the 
intestine (75). PL can then play a role in the ability of HDL to accept excess cholesterol 
from cells during RCT (72). 
Large HDL has been shown to be the major acceptor of oral PL, although all HDL 
species incorporate some PL (75). Previous studies have provided evidence that PL 
enriched HDL may improve the ability to mobilize cholesterol from cells, as well as 
enhance ABCG1 and SR-BI as preferred acceptors of large HDL (72,76). After mass 
spectrometry analysis of PL species, there was an increase in phosphatidylethanol-
amine, and a positive association with increase in HDL-C in the egg group (71). 
Additionally, CE enrichment of HDL was observed, and this has been hypothesized to 
increase SR-BI mediated uptake, as well as producing large HDL species (77). A PL 
feeding study in rats found an decrease in serum cholesterol and decrease in intestinal 
cholesterol absorption when rats were fed phosphatidylcholine (PC) from 3 sources over 
4 weeks (78). Additionally, whole egg consumption has been demonstrated to increase 
number and size of HDL particles, which may have the potential to carry more cholesterol, 
thus increasing RCT (64). Eggs are an abundant source of dietary cholesterol, although 
studies have shown that the increased intake of cholesterol from eggs will not be harmful, 
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and may reflect an increase in HDL-C and LDL-C, most often occurring with increases in 
particle size and number (53,63,79). An egg feeding study to examine excess cholesterol 
intake found increased CETP activity, which may be associated with increased RCT, 
through the CE enrichment of LDL, which can be taken up by the liver where CE is 
removed and metabolized by LDL receptor pathway (28). If whole egg consumption is 
improving the lipid accepting capacity of HDL by involvement of PL species, and creating 
specific HDL with the ability to carry more cholesterol and enhance RCT, then eggs may 
play a very important role in enhancing RCT and reducing risk of CVD. 
Implications of Egg Consumption on HDL Metabolism 
 The habitual consumption of eggs has shown to raise plasma HDL-C in cholesterol 
hyperresponders, and raise or maintain HDL-C levels in hyporesponders (53). The 
increase in HDL-C is regarded as CVD protective, as HDL as the major lipoprotein in 
RCT.  Beyond this, eggs may provide HDL remodeling to a more anti-atherogenic 
lipoprotein particle size and concentration, addition and incorporation of antioxidant 
carotenoids and preferential incorporation of PL to enhance RCT.  
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Section 3 
 
Appetite Regulation 
 
Introduction 
Appetite regulation is an intricate system of both biological and psychological 
functions that control intake and inhibition of eating. During the consumption of a meal, 
an individual firstly feels satiation, which occurs during an eating episode and brings 
eating to an end. Satiety, starts soon after the end of the eating period and prevents 
further eating before the return of hunger (80).  The basis of this process, identified as the 
satiety cascade, identifies events following hunger, or the signal to initiate the eating 
process to the series of events that terminate consumption (81). Various hormones and 
central nervous system (CNS) functions are involved in regulation of food intake, and can 
act rapidly or slowly to uptake nutrients or promote stability and body fat stores.  Dietary 
choices, in the form of macronutrient composition or specific-food selection can drastically 
vary the functions of appetite regulation. Understanding the complex mechanism of 
appetite regulation, identifying food options and practices to regulate and increase satiety 
while reducing hunger is important to the prevention of obesity and related complications.  
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Appetite Regulation 
 Appetite regulation is a central mechanism with dependency on body weight 
regulation through dietary intake, central nervous system function, circulating appetite 
hormones, and psychological wants and needs. Hunger signals begin with sympathetic 
nervous system activation of the X/A-like cells in the stomach, during gastric emptiness 
to release the hormone, ghrelin (82). When secreted and activated, ghrelin is the key 
regulator of nutrient sensing, meal initiation and appetite (83).  Acylated ghrelin will bind 
to growth hormone secretagogue receptors in the brain to signal meal initiation. Following 
the initiation of eating, increase in blood glucose and other metabolic signals will induce 
meal termination, termed satiety. It is a two-step process, with physiological aspects of 
reward and pleasure and post-ingestive signals controlled by gut peptide hormones, 
cholecystokinin (CCK) and peptide YY (PYY), and others. CCK has been shown to reduce 
food intake in a dose-dependent manner, by responding to meal initiation. It plays an 
important role in stimulating contraction of the gallbladder and inhibition of gastric 
emptying (84). PYY is influenced by meal consumption, composition and calorie content. 
Release of this protein has a food intake-inhibiting effect (85). From meal to meal, long 
term satiety is controlled by insulin, glucose, amino acid concentrations in the blood and 
processing of nutrients through the gastrointestinal system (80). Leptin, which is secreted 
by white adipocytes, are proportional to fat mass, and has the ability to reduce food intake 
and body while increasing energy expenditure (86). It plays an important role in controlling 
body weight and works in opposition to ghrelin. Another regulator, insulin, has a similar 
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role to leptin with the relationship to food intake and energy intake, via the facilitation of 
glucose uptake (87,88). The interworking of the neuroendocrine system to utilize 
circulating hormones to relay information about energy balance (intake and expenditure) 
with brain pathways that control eating and energy output are the emerging pathways that 
need to be elucidated in order to understand how our bodies control appetites and weight. 
Of added importance to the field of nutritional sciences, is the impact of certain macro- 
and micro nutrients along with specific whole foods and their roles in this complex control 
system. 
Macronutrients 
When comparing macronutrients, protein is suggested to be more satiating, than 
carbohydrates and fat (89) Carbohydrate consumption has a moderate effect on long-
term satiety, varying on type of carbohydrate, while fat has been shown to have a weak 
effect on satiation (90). This has been evaluated under various study conditions, such as 
short term, over 24-hours, post-prandial and over months. In acute feeding studies, 
carbohydrates have similar satiation, but the effect is diminished over time as compared 
to protein (91). The proposed mechanism is evidenced by rapid gastric emptying following 
the feeding of animal protein, which increases plasma amino acids concentrations 
postprandially (92). In a single-blind, cross-over study, participants consumed two 
isocaloric high protein or high fat breakfasts. Results showed the high protein breakfast 
decreased ghrelin secretion, which was correlated with insulin, glucagon and CCK 
concentrations, and decreased gastric emptying rate (93).This may impact satiety due to 
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an increased stimulatory effect of gastric hormones, however, this effect can vary among 
different amino acids and specific proteins. 
High Quality Protein 
High Protein Diets 
 The use of high protein diets, in an effort to enhance weight loss has been more 
popular recently with the up rise of low carbohydrate diets. The basis for this dietary 
pattern is the association of protein with feeling of satiety and the following decreases in 
calorie intake. Popular low-carbohydrate, high-protein diets have shown results of greater 
weight loss at 3 and 6 month follow up as compared to a low-fat, high carbohydrate diet 
(94). A study that increased protein, while maintaining carbohydrates found sustained 
decrease in caloric intake, ad libitum, with suggested relation to leptin sensitivity and 
ghrelin reduction. Results also found increased energy expenditure, diet induced 
thermogenesis and no significant weight gain or hunger (95). There are two main theories 
behind dietary protein and promotion of negative energy balance and possible weight 
loss. Firstly, the ability of dietary protein to increase energy expenditure through diet-
induced thermogenesis. This has been shown to have a more powerful effect following 
consumption of animal protein as compared to equal caloric loads of carbohydrate or fat 
(96). Secondly, the proposed increased satiety of protein as compared to other 
macronutrients. This has been shown in both short- and long-term feeding studies and 
accompanied by subjective appetite measures. Subjective measures assess appetite 
sensations by utilizing visual analog scales (VAS), in which study participants indicate 
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feelings of satiety, hunger, fullness, prospective food consumption, thirst, well-being, and 
desire to eat something fatty, sweet, salty or meaty (97). These measures are critical, as 
appetite regulation has tight connection to psychological reward and pleasure responses 
that control intake. A study that coupled the addition of egg or egg substitute with a CRD 
found benefit in body composition and lipid parameters following egg consumption. The 
addition of the eggs did not deter the benefits of CRD, but improved fasting insulin levels 
and insulin sensitivity. No change in appetite hormones, ghrelin and PYY were observed, 
which was attributed to increased leptin sensitivity brought about by CRD.  Although all 
subjects felt less hungry and more satisfied as reported by VAS. The combination of egg 
intake with CRD was suggested as an effective weight loss strategy, and overall decrease 
in hunger attributed to high protein percentage of the diet, contributed by eggs (98).  
Eggs: High Quality Protein 
The average American consumes about 250 eggs per year, and average 
consumption per capita has been steadily increasing over the last 20 years (99). Eggs 
are a modest calorie (~70 per large egg) food, typically consumed at breakfast time. 
Economically, eggs are easily accessible, low cost and have a wide range of culinary 
versatility, as both a single food for consumption and as an emulsifier for combination 
dishes. Nutritionally, eggs are a source of high quality protein, vitamins, minerals, lecithin, 
choline, and carotenoids (100). What makes eggs unique is the variety of nutritional 
components packaged into a single food. Due to the previously listed attributes of eggs, 
there is a developing connection between eggs and a suspected role in satiety. 
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According to My Plate, eggs are listed under “protein foods group,” with need listed 
as dependent on age, sex, and level of physical activity. One large egg is considered a 
one ounce equivalent protein food group, with adult women and men recommended to  
consume between 5-6 ounces per day (101). What constitutes the inclusion of eggs in 
the protein group, is one egg contains all dispensable and indispensable amino acids, 
and has high digestibility, ~95%. This is what classifies eggs a “high quality and complete” 
protein. Eggs are listed as having a very high biological value, which measures protein 
quality by determining nitrogen used for tissue formation divided by nitrogen absorbed 
from food, to determine nitrogen utilized (102,103). Regular consumption of high quality 
protein has been linked to normal birth weight, lean body mass gain in elderly, and various 
other benefits to multiple population groups (104). Specific benefits of essential amino 
acids include: stimulated muscle synthesis, stimulator of rapamycin complex pathway, 
decreased muscle breakdown through associated cellular signaling and many more 
functions (102). 
Dietary Interventions  
  In egg feeding studies, a macronutrient shift toward a high protein diet has been 
observed. A study in healthy overweight and obese individuals compared eggs to ready 
to eat cereal to examine satisfaction. Results found lower circulating levels of ghrelin and 
increased PYY following egg consumption. Authors cite a suggested alleviation of protein 
concerns from liver and kidney function due to the added high quality protein from eggs 
(105). In another study comparing eggs to a bagel breakfast in adolescences, lunchtime 
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PYY was significantly increased after consuming eggs, however this was not correlated 
with reduced food intake. Authors mention this population may be better at controlling 
appetite regulation, as compared to adults who are more likely to resist feelings of satiety 
(106). However, a study by another group that compared an egg based breakfast to a 
cereal or oatmeal breakfast found significantly reduced short-term energy intake, ~70 
calories at lunch. This finding suggests that a high protein breakfast of eggs much reduce 
calorie intake throughout the day (107). This compared to a study in adults with eggs and 
cottage cheese found no differences in weight changes other time and concluded that the 
satiating power of both foods was equivalent (108). Conversely, a study where overweight 
women consumed an egg versus bagel isocaloric breakfast followed by lunch, found that 
following the egg breakfast women had greater satiety and significantly reduced short-
term food intake. Not only did participants consume less at lunch, the energy deficit was 
not compensated for in the following 24 hours. Authors noted that while both breakfasts 
diminished hunger during the pre-lunch period, the egg breakfast reduce hunger to a 
greater extent, which may be attributed to the protein content of eggs. Biochemical 
markers measured resulted in decreased insulin response and blood glucose, with 
increased CCK and delayed gastric emptying following the egg breakfast (105).  
Ghrelin, the hunger hormone, has been shown to promote food intake and assist 
weight gain. In a postprandial feeding study, a greater decrease in plasma ghrelin was 
seen after carbohydrate and protein ingestion as compared to fat (109). Postprandial 
feeding studies have shown that ghrelin levels change as the day continues and have a 
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relationship with energy balance and blood glucose. It has been shown that ghrelin is 
upregulated with a negative energy balance, to induce eating and down regulated with a 
positive energy balance (82). In a cross-over study that compared an egg based breakfast 
to a bagel breakfast, glucose and insulin were decreased following egg consumption as 
compared to the high carbohydrate breakfast. Circulating plasma ghrelin was decreased 
following egg consumption postprandially, which authors attributed to protein and fat 
content and digestion, which has been suggested to play a role in ghrelin suppression 
(110).  Additional subjective analysis reported reduced hunger and increased satisfaction 
following the egg breakfast which resulted in reduced energy intake at lunch and 24 hours 
post intervention (111).  
Glycemic Control 
 Glycemic Index (GI) is defined as blood glucose measured in response to 
consuming a food, the immediate impact on blood glucose levels. Glycemic Load (GL) 
depends on the quantity of food eaten, and is an indication of glucose available for energy 
or storage following a meal (112). Eggs have no GI value, or a value of 0, since they 
contain no carbohydrates. Even if consumed in large quantities, eggs consumed as a 
single food will not induce a significant rise in blood glucose (113). Thus, GL is typically 
not calculated for egg consumption alone, since the inability to raise blood glucose will 
have no impact on glucose available for storage following a meal. A rise in GL following 
a meal with eggs can then be concluded to be from additional foods consumed at that 
meal. Based on this information, the consumption of eggs should be considered safe for 
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individuals with diabetes, although given the controversial past of egg research, data is 
still unclear. A study in adults with type 2 diabetes compared two different breakfasts, with 
either 2 eggs per day or the exclusion of eggs. Results found that the inclusion of eggs in 
the diet did not affect glycated hemoglobin (HbA1c) or systolic blood pressure, which 
while not statistically significant, was cited as clinically significant by the research team, 
which mentioned this study may have been blunted by sample size and duration.  The 
inclusion of eggs also reduced BMI, visceral fat rating, waist circumference and percent 
body fat as compared to the exclusion of eggs in the habitual diet. Additionally, insulin 
resistance was increased with the exclusion of eggs. Study parameters used HbA1c as 
the measure of glycemic control in the population, citing no difference between dietary 
interventions, thus no detrimental impact on this marker or insulin resistance. The study 
concluded that the inclusion of 2 eggs per day in the habitual diet of individuals with type 
2 diabetes will not affect HbA1c levels, but improve anthropometric measures (114).  In 
a study that compared an egg and sausage-based breakfast to a pancake breakfast in 
pre-menopausal women both appetite and glucose homeostasis were evaluated. After 
the high protein egg and sausage-based breakfasts there were reductions in perceived 
hunger and increased satiety evaluated by VAS, which corresponded to decreased levels 
of postprandial glucose and insulin, indicating increased glycemic control. Additionally, 
reduced energy intake was observed at lunch suggesting long-term effects of consuming 
a high protein-egg based meal at breakfast (115).  
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Implications of Egg Consumption on Appetite Regulation 
 The information reviewed highlights the role of egg consumption, as a high-quality 
protein that is part of appetite regulation and control. The role of dietary protein, from eggs 
has shown several benefits in satiety, hormone and weight regulation. While studies 
provide promising results, it is still unknown how consumption effects all populations. 
More research is needed in overweight/obese populations where appetite regulation may 
not be properly functioning. The understanding of egg consumption with respect to 
appetite regulation may be an effective dietary treatment for those interested in a high 
protein, low carbohydrate diet for weight loss.   
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Section 4 
 
TMAO  
 
Introduction 
Trimethylamine N-oxide (TMAO) is derived from dietary sources which are 
metabolized through the action of gut microflora, then transformed to trimethylamine 
(TMA), a gas that is absorbed into the circulation and further metabolized to TMAO (116). 
Recently, some data has suggested a potential link between TMAO levels and CVD (117). 
A study in mice using a dietary supplement of choline resulted in up-regulation of 
numerous macrophage scavenger receptors related to atherosclerosis (118).  Choline, is 
a precursor to TMAO, thus has become a current topic of controversy when determining 
safety of egg consumption. Choline is a bioactive lipid, similar to the family of B vitamins, 
has a role in brain, cell and nerve function and lipid transport and metabolism. Currently, 
it is suggested that ~90% of Americans are below the AI for choline intake (119). As eggs 
account for the third highest food consumed with choline behind chicken livers and 
salmon, they have been targeted as foods that may be linked to TMAO production.    
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TMAO metabolism 
Dietary sources of choline are ingested and metabolized by gut microbiota to 
produce the intermediate compound, TMA. The microbiota convert the choline moiety into 
TMA, so various nutrients are able to be converted (120). It is well known that gut 
microbiota varies greatly among individuals and colony population depends on many 
different factors such as diet, lifestyle, and health status (116). The individual gut 
microbiota taxa have been linked to immune function, activation and absorption of 
nutrients and have roles in development of diseases like obesity and diabetes (121).  
Once metabolized, TMA is oxidized by flavin-containing monooxygenases (FMO) to form 
TMAO (120). Supplementation of choline, TMAO or betaine, was shown to be 
proatherogenic and associated with cardiovascular risks (118). A hypothesis was formed 
that any nutrient with a trimethylamine structure, similar to that of choline could induce 
TMAO and increase CVD risk (122). TMAO levels are increased after the consumption of 
foods rich in choline, carnitine lecithin, and TMAO (120,123,124). High levels of TMAO 
are suspected to negatively alter cholesterol metabolism, by decreasing reverse 
cholesterol transport, decrease the bile acid pool and increase cholesterol accumulation 
in macrophages for increased foam cell formation (122). Based on these hypotheses, is 
it unclear if plasma TMAO increases risk for CVD. 
Clinical Studies 
 As eggs are a rich source of choline in the diet several studies have undertaken 
the task of determining whether intake of whole eggs, as a source of choline increase 
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plasma TMAO and increase risk of CVD. In a large prospective cohort study of 4007 
adults with previous history of CVD and high risk of cardiovascular events, it was reported 
that at baseline TMAO levels were lower in individuals who have not experienced a prior 
CVD event. At a 3-year follow up, participant who have major cardiovascular events had 
higher plasma TMAO than those who did not have events. Authors cite this as a clinical 
outcome of TMAO levels as a predictive tool for CVD risk (125). A study with 40 healthy 
men consumed dietary phosphatidylcholine, in the form of two eggs (~250 mg/choline) at 
three separate time points with antibiotic washouts in between. Results found generation 
of TMAO from dietary phosphatidylcholine, and a role of intestinal microbiota in its 
production (125). A longitudinal study was conducted in a small group of individuals (n=6) 
who consumed egg yolks (0, 1, 2, 4, 6) at different visits. Results found increased 
formation of TMAO with ³ 2 eggs, with ~14% of total choline being converted to TMAO. 
Authors noted great variability among participants and no increased inflammation after 
egg consumption, therefore were inconclusive on relation to CVD risk (126).  A study 
where healthy, young participants consumed eggs (1, 2, 3) in a dose dependent manner 
over 14 weeks found no change in plasma TMAO between groups or over time. 
Interestingly plasma choline concentration increased significantly which each additional 
egg consumed, yet there was no increase in TMAO production. Authors note the small 
conversion rate of choline to TMAO, and suggest the relationship is clouded by inter-
individual variation of gut microbiota species and FMO activity (127).   
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Considerations 
There are several considerations when determining the relationship between 
nutrients with choline moieties and TMAO production. The length of interventions 
currently available in the literature is rather short. Many studies consist of single feedings 
with post-prandial sample collection. Since inter-individual variability is a large 
confounder, more long term feeding studies are needed to truly understand the 
relationship. Inter-individual variability is a consideration for many reasons. The gut 
microbial taxa can be significantly different from person-to-person and is dependent on 
many factors (121). A study comparing the fecal microbial composition of 
vegan/vegetarians to omnivores found a clear differentiation in enterotype and major 
species, concluding dietary pattern have much to do with gut microbiota taxa (120). 
Additionally, functionality of FMO3 is a consideration, as those without FMOs cannot 
properly convert TMA to TMAO, causing fish malodor syndrome (128). However, 
expression and functionality of FMOs in those not afflicted by fish malodor syndrome can 
vary. A study found that FMO3, the main liver enzyme used in the conversion of TMA to 
TMAO, was highly expressed in apoE -/- female mice and upregulated by estrogen, while 
androgens was associated with decreased FMO3 in male mice. FMO3 expression was 
found to be induced by farnesoid X receptor (FXR), which is also activated by bile acids. 
Authors concluded FMO3 expression and activity are significant correlated, and depend 
on both dietary factors and gender (122). 
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Despite the findings of the aforementioned data, there are still gaps to determine 
a dangerous level of plasma TMAO and if so, which nutrients are involved in producing 
it. The major dietary sources of TMAO are choline, carnitine, lecithin, and seafood which 
have many other published beneficial properties in the foods in which the sources are 
found. Therefore, the recommendations are unclear as if to limit intake of choline-rich 
foods or to target composition of microbiota to effectively reduce TMAO levels. 
Conclusions 
The data presented in this review highlights the various biological systems and 
nutritional impacts of egg consumption on the human body. First deemed dangerous over 
50 years ago, eggs have been shown in extensive clinical trials to document that they 
pose no increased CVD risk, have active roles in HDL functionality and appetite regulation 
while providing high quality protein, vitamins and minerals to the everyday diet. These 
findings provide the evidence needed to consume eggs daily, to provide health and well-
being benefits.   
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Introduction 
As evidenced by the previous chapter, there is still uncertainly surrounding the 
consumption of eggs and relative benefits. However, numerous studies have shown the 
potential for egg consumption to have benefits beyond nutrition in regards to lipid and 
lipoprotein metabolism, gene regulation, and antioxidant capacity (1–3). The purpose of 
the dietary intervention conducted was to assess the health benefits of the consumption 
of two eggs per day for breakfast as compared to a food considered to be heart healthy, 
oatmeal (4). The study was not aimed to prove one food is more beneficial than the other, 
but simply to show the safety of habitual consumption and nutritional equivalences of the 
breakfast foods, while identifying additional benefits of egg consumption.    
The benefits beyond nutrition comprise the third aim, as outlined in the 
introduction. As presented in the previous chapter, the specific components of eggs hold 
promise for modulation and benefit of mechanisms related to CVD risk. The intervention 
allowed for collection of samples that could be analyzed beyond basic nutrition to examine 
the potential for this. The findings from this dietary intervention are being prepared for 
publication or have been published in scientific journals (5,6).  
Experimental Design 
Population 
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The study population for this study was young, apparently healthy men and women 
between the ages of 18 and 30 years. Healthy volunteers are defined as, “someone with 
no known significant health problems who participates in clinical research voluntarily (7).” 
Healthy volunteers are critical to research, since data from these participants can 
determine “normal” ranges and limits for various biomarkers. This information is used for 
comparison to disease populations for diagnosis and treatment. Healthy volunteers may 
also receive direct benefit from participating in studies and information gathered is 
important to developing recommendations for the general healthy population (7).   
Recruitment 
For the purpose of this study, 55 participants were assessed for eligibility. Previous 
study results have found significant differences in HDL-C between egg and egg substitute 
groups using a crossover design with 40 participants (8). Based on the standard deviation 
and using a Z value of 1.96 (95% confidence interval) it was estimated that 40 subjects 
would be sufficient to observe significant differences in plasma HDL-C between groups 
(9–11). We recruited 50 subjects to allow for attrition. Participants were recruited via 
emails and flyers, targeted specifically to University of Connecticut students and 
employees. Inclusion criteria for participation was men and women aged 18-30 years, 
proficient in English, with a body mass index (BMI) 18.5 – 30 kg/m2, and willingness to 
consume eggs or oatmeal daily, while restricting intake during the alternate phase of 
treatment. Participants were excluded if they had personal history of liver disease, renal 
disease, diabetes, cancer, stroke or heart disease as assessed by a medical history 
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questionnaire. They were also excluded if the participant was taking any glucose lowering 
drugs or supplements, pregnant, lactating, or had allergy to eggs, celiac disease or gluten 
sensitivity. Lastly, if lab values indicate resting blood pressure (BP) > 140/90 mmHg 
(average of 3 readings), fasting TG > 500 mg/dL, fasting glucose (GLU) > 126 mg/dL, or 
fasting TC > 240 mg/dL, the subject was excluded from participation.  
Screening 
To determine if subjects were eligible for the study, a screening visit was 
conducted. Potential subjects were asked to fast (refrain from consuming any food or 
beverages with calories, while drinking plenty of water) for 12 hours. Upon arrival potential 
subjects were consented, using the “consent form for participation in a research study” 
approved by the University of Connecticut Institutional Review Board (IRB),	 protocol 
#H14-032. The purpose of the consent form is to give participants all the needed 
information to understand why the study was being done, the risks involved, the 
inconveniences and discomforts during participation, and the ability to ask any additional 
questions. After the subject was consented and signed the document, additional 
measures were taken to determine qualification for participation the study; these 
measures are described in recruitment and study measures section of this chapter. 
Participants were asked to complete a medical history form, which asks about personal 
and family medical history. Analysis of the data from the medical history forms have been 
published (6). Following the screening process, 50 total participants (26 females and 24 
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males) were enrolled; 5 screened subjects chose not to participate in the intervention 
(Figure 3.1).  
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Figure 3.1: Flow Chart of Eggs and Oats Study1  
1Forty-eight of 50 participants completed the study, as two did not meet the requirements 
for oatmeal consumption during that arm of the intervention (5). 
Dietary Intervention 
The study was a crossover design depicted in Figure 3.2 where participants were 
randomly allocated to consume either two eggs per day for breakfast or one packet of 
oatmeal per day for breakfast for 4 weeks. Dietary intervention nutritional data is 
presented in Table 3.1. During the 3-week washout in between the intervention periods, 
participants consumed no eggs or oatmeal. The total intervention time was 11 weeks, 
Assessed for eligibility 
(n = 55)
Excluded (n = 5)
-Did not wish to participate
Randomized Cross-over
(n = 50)
Egg breakfast 
(n = 23)
No drop-outs
Oatmeal breakfast 
(n = 27)
Drop out (n = 2)
-Could not follow 
oatmeal breakfast
Crossed-over to 
alternate breakfast (n = 48)
Final analysis (n = 48)
Allocation
Follow-up
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and took place between August-December 2014. Each participant began by consuming 
two eggs (n = 23) or one packet of oatmeal (n = 27) for 4 weeks (Figure 3.1), then 
refrained from eating eggs or oatmeal for 3 weeks during washout. The participant then 
crossed over to the alternative breakfast for the remaining 4 weeks.  
Figure 3.2 Overview of Study Design
 
Study Measurements 
There were 4 major points of data collection: baseline (before intervention), end of 
intervention period 1 (washout), baseline 2 (after washout, before alternative treatment), 
and end of intervention period 2. Each of the following study measures was performed 
during the 4 data collection points as depicted in Figure 3.2. 
n = 50
26 males
24 females
Screening
OATS
Week 0-4
EGGS 
Week 0-4
EGGS 
Week 7-11
OATS 
Week 7-11
Study 
Completion
Screening 0       1 2       3 4          5       6          7       8          9 10       11    weeks
Baseline
Week 0
Washout
Week 4-7 
Study Design
Randomization
n = 48
24 males
24 females
Dropout = 2
	
	
	
66	
 Table 3.1 Nutrient Composition of Intervention Foods1 
1Dietary intervention foods selected based on the affordability and convenience of 
products, all foods were picked up weekly by participants. Participants were able to 
prepare foods in any way desired, without the additional of eggs or oat-based products. 
 
Blood pressure: Participants were seated, resting and in a comfortable position for 
at least 5 minutes. An automated blood pressure cuff on the left arm recorded 3 
measurements with at least 1-minute breaks in between readings. The average of the 3 
readings was documented. 
Anthropometric measures: Height, weight, waist circumference was assessed; the 
participant was asked to stand straight and tall without shoes against a standing 
stadiometer where height was recorded in centimeters. Weight was measured in 
kilograms using a digital scale and rounded to the nearest tenth. Waist circumference 
was measured using a non-flexible measuring tape, placed directly on the skin on the top 
of the iliac crest. The measurements were taken 3 times, and an average measurement 
was recorded in centimeters.  
Blood collection: Blood draws occurred under safe and sanitary conditions. For 
baseline and following washout, 20 mL of blood was collected, and following each 
Nutrient 2 Large Eggs 1 Packet Oatmeal 
(Apple Cinnamon) 
Calories 140 160 
Total Fat 10 g 2 g 
Protein 12 g 4 g 
Carbohydrates 0 g 33 g 
Cholesterol 370 mg 0 mg 
Dietary Fiber 0 g 4 g 
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intervention period 80 mL of blood was collected. The blood samples collected at baseline 
and following the washout were immediately centrifuged (x2000g) to separate plasma 
which was stored at -80° C for further analysis. Blood samples collected following the 
intervention periods were separated: 20 mL of blood was treated as previously described, 
and 60 mL of blood utilized for isolation of PBMC.  
Records: Participants were required to complete diet and exercise records, and 
satiety scales. Dietary habits are recorded using 3-day dietary records completed prior to 
4 major data collection time points. Participants were required to record all food and 
beverages consumed during 3 days (1 weekend day, 2 non-consecutive weekdays). This 
dietary information was analyzed using Nutrition Data System for Research (NDSR). 
Days concurrent to dietary records, exercise records were completed, which indicate the 
type and amount of time subjects spent exercising. Data was compiled by amount of 
activity in minutes. Lastly, participants completed visual analog satiety scales (VAS) 
before each meal prior to each dietary record entry. The satiety scales consisted of 8 
questions, which correspond to how they felt before consuming breakfast, lunch and 
dinner. Participants marked along a 10-cm line to indicate their level of satiety or hunger. 
The values along the line were measured to the tenth decimal place, assigning a 
numerical value to the satiety of the participant. 
Participants were required to consume no less than 70% of their designated intervention 
foods and compliance was monitored by daily self-report. At the completion of the study, 
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participants received $150 in compensation and information about their lipid values, and 
other biomarkers.   
Subject Characteristics and Nutrient Intake 
Subjects characteristics at baseline are presented in Table 3.2. All values fell within 
criteria for considering this population, apparently healthy by self-report. Additional 
information on antioxidant intake, activity level and indicators for chronic disease from this 
population at baseline has been published (6).  
 Table 3.2 Baseline Characteristics of Study Subjects1 
 1Values are presented as mean ± SD; n=50, adapted from (5). Lipids, glucose and CRP were 
measured by Cobas c 111 analyzer, as described (5).  
 
  
Parameter EGGS OATMEAL 
Age (years) 22.5 ± 3 23.8 ± 3 
Gender (n=F/M) 14/9 11/16 
BMI (kg/m2) 23.6 ± 2.1 23.1 ± 2.1 
WC (cm) 81.9 ± 7.1 81.6 ± 5.4 
Systolic BP (mmHg) 113.3 ± 13.5 114.4 ± 10.4 
Diastolic BP (mmHg) 73.1 ± 6.3 73.7 ± 7.5 
Total Cholesterol (mg/dL) 158 ± 33.6 150 ± 25.3 
LDL-C (mg/dL) 81.3 ± 28.9 69.3 ± 21.3 
HDL-C (mg/dL) 63.6 ± 13 65.1 ± 24.9 
LDL-C/HDL-C 1.3 ± 12.5 1.1 ± 3.7 
Triglycerides (mg/dL) 69.1 ± 77.2 77.3 ± 33.9 
Glucose (mg/dL) 93.3 ± 7.6 91.2 ± 6.2 
CRP (mg/dL) 0.2 ± 0.4 0.1 ± 0.1 
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Abstract 
Eggs contain high quality protein, vitamins, minerals and antioxidants, yet regular 
consumption is still met with uncertainty. Therefore, the purpose of this study was to 
compare the effects of consuming two eggs per day or a heart-healthy oatmeal breakfast 
on biomarkers of cardiovascular disease (CVD) risk and satiety measures in a young, 
healthy population. Fifty subjects participated in a randomized crossover clinical 
intervention; subjects were randomly allocated to consume either two eggs or one packet 
of oatmeal per day for breakfast for four weeks. After a three-week washout period, 
participants were allocated to the alternative breakfast. Fasting blood samples were 
collected at the end of each intervention period to assess plasma lipids and plasma total 
ghrelin. Subjects completed visual analog scales (VAS) concurrent to dietary records to 
assess satiety and hunger. Along with an increase in cholesterol intake, there were 
significant increases in both low-density lipoprotein (LDL) and high-density lipoprotein 
(HDL) cholesterol following the egg consumption period (p < 0.01). However, there was 
no difference in the LDL/HDL ratio, a recognized biomarker of CVD risk, nor in the plasma 
glucose, triglycerides or liver enzymes, between diet periods. Several self-reported satiety 
measures were increased following the consumption of eggs, which were associated with 
lower plasma ghrelin concentrations (p < 0.05). These results demonstrate that compared 
to an oatmeal breakfast, two eggs per day do not adversely affect the biomarkers 
associated with CVD risk, but increase satiety throughout the day in a young healthy 
population. 
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Introduction 
Cardiovascular disease (CVD) is currently the leading cause of death among adult 
men and women in the United States [1]. In order to prevent its development, beneficial 
diet and lifestyle habits should be implemented while young and healthy. Habitual 
breakfast consumption has been associated with a healthy lifestyle and good nutritional 
status, while studies have reported it to be predictive of lower body mass index (BMI), 
and inversely related to obesity later in life [2,3]. Whole eggs, which are typically 
consumed as a breakfast food, are inexpensive, readily available, and contain high quality 
proteins, essential vitamins and minerals, as well as the antioxidant carotenoids lutein 
and zeaxanthin, lecithin, choline and cholesterol [4]. In the past, whole egg consumption 
has been controversial, due to the cholesterol content of eggs (~185–200 mg/egg), 
although this amount of dietary cholesterol has been long since identified as a non-
significant independent risk factor for CVD [5]. Currently, the American Heart Association 
is recommending egg whites without the yolks as a heart-healthy source of protein [6], 
despite the removal of the 300 mg/day limit of dietary cholesterol in the 2015–2020 
Dietary Guidelines for Americans [7]. The negative connotation associated with dietary 
cholesterol has been challenged by numerous studies demonstrating the lack of 
increased biomarkers associated with risk of CVD and the beneficial effects of daily egg 
consumption [8–10]. Whole egg consumption studies have not only resulted in the 
absence of increases in factors associated with CVD risk but also in improved markers of 
chronic inflammation, glucose intolerance, and insulin resistance in several distinct 
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populations: children, individuals with metabolic syndrome and people with diabetes [11–
14]. A previous study showed that the consumption of one egg per day reduces insulin 
resistance and contributes to higher weight loss associated with increased satiety [15]. In 
several studies, when compared to an isoenergetic, equal-weight breakfast, an egg-
based breakfast has been shown to increase satiety and decrease energy intake 
[13,16,17]. Satiety, or the feeling of satisfaction, can be measured objectively, by 
biochemical measures, or subjectively by self-report. Increased satiety can lead to 
changes in nutrient intake patterns, which can have favorable roles in the reduction of 
CVD risk [18–20]. Specifically, ghrelin, a growth hormone–releasing peptide secreted by 
the stomach in a fasted state, promotes food intake and has roles in energy balance and 
weight maintenance, as well as proposed roles in various body systems [21]. The 
regulation of this hormone is affected by both chronic energy balance and acute feeding. 
It is a marker for increased appetite, and is associated with a counter hormone, leptin, 
which has been implicated in the regulation of adipocyte homeostasis [18,22,23]. 
Decreased levels of ghrelin have been related to decreased appetite and can increase 
weight loss [24,25]. 
For the purpose of this study, whole egg consumption was compared to oatmeal 
consumption. Oatmeal is also a good source of fiber, B vitamins, iron, magnesium, and 
selenium, and an American Heart Association “certified heart healthy food” [26]. The main 
benefit of oatmeal for CVD protection is the ability to lower low-density lipoprotein 
cholesterol (LDL-C), which can be attributed to its soluble fiber content [27]. The main 
objective of this study was to investigate the effects of two different breakfasts on 
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anthropometrics, dietary patterns, lipid profile, and satiety in a healthy population in order 
to evaluate the biomarkers of CVD risk and effect on appetite. We hypothesized that 
compared to daily consumption of oatmeal, the intake of two eggs per day would not 
result in changes of CVD risk biomarkers, but would increase satiety in a young, healthy 
population.  
Materials and Methods  
2.1. Experimental Design 
Fifty healthy individuals (26 females and 24 males) between the ages of 18–30 years 
were recruited to participate in an 11-week, randomized, crossover, intervention study. 
Participants were mainly college students recruited from the University of Connecticut, 
Storrs, CT and young professionals from local surrounding communities. Based on the 
standard deviation from our previous studies and using a Z value of 1.96 (95% confidence 
interval) we estimated that 40 subjects would be sufficient to observe differences in 
plasma high-density lipoprotein cholesterol (HDL-C) between groups [11,12,15]. We 
recruited 50 subjects to allow for attrition. The study took place between August–
December 2014. 
Participants signed a written, informed consent form prior to any measures or 
experimental procedures. Inclusion criteria included age (18–30 years), body mass index 
(BMI) (18.5–29.9 kg/m2) and willingness to consume the intervention foods daily.  
Exclusion criteria included plasma triglycerides (TG) > 500 mg/dL, total cholesterol 
(TC) > 240 mg/dL or glucose (GLU) > 126 mg/dL. Current or previous history of liver 
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disease, renal disease, diabetes, cancer, endocrine disorders, metabolic disorders, 
stroke or heart disease, taking glucose lowering drugs or supplements, current pregnancy 
or lactation, BMI ≥ 30 kg/m2, blood pressure >140/90, egg or gluten allergy/sensitivity or 
celiac disease. All analysis was performed blinded to breakfast allocation. All visits took 
place in the Nutritional Sciences Department at the University of Connecticut, Storrs, CT. 
This study was approved by the Institutional Review Board at the University of 
Connecticut (protocol #H14-032). This trial is registered at ClinicalTrials.gov as 
NCT02181244. 
2.2. Dietary Intervention 
Enrolled participants were randomly allocated to consume either two eggs per day 
(EGGS) or one packet of oatmeal per day (OATS) for four weeks (Big Y Foods, Inc., 
Springfield, MA, USA). Following a three-week washout, participants crossed over to the 
alternate intervention food for four weeks. Each daily serving of two eggs contained 370 
mg cholesterol, 0 g carbohydrate, 12 g protein, 10 g fat, 0 g fiber and 140 calories. Each 
daily serving of one packet of oatmeal had 0 mg cholesterol, 0–14 g carbohydrate, 3–4 g 
protein, 1.5–2 g fat, 3 g fiber and 100–160 calories depending on the flavor choice, of 
which there were five. Participants were instructed to consume the intervention foods as 
the first meal of the day, and were allowed to add vegetables, meat, cheese, syrup, 
yogurt, etc. to their breakfast intervention food, if desired. Participant compliance was 
monitored daily by self-report and bi-weekly visits to our laboratory for product pickup. 
During the intervention and washout periods, participants were asked to avoid consuming 
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whole eggs or foods containing predominately eggs or oats. Aside from treatment, 
habitual dietary intake, exercise, medication usage, and supplement intake was 
maintained throughout the study. 
2.3. Blood Collection and Processing  
After a 12 h overnight fast, blood was drawn at baseline, and at the end of each 
dietary period. Whole blood was collected from participants in EDTA and SST blood 
collection tubes and was centrifuged at 2000× g for 20 min at 4 °C. Plasma and serum 
were collected and aliquots were placed at −80 °C for storage. 
2.4. Anthropometrics, Blood Pressure, Waist Circumference, and Dietary Intake 
Anthropometric measures of weight, height, BMI, and waist circumference (WC), and 
dietary intake were collected from participants at the end of each dietary period. Weight 
was measured to the nearest 0.1 kg, height to the nearest centimeter, and BMI was 
calculated. BP was measured with an automated blood pressure monitor (Omron, 
Healthcare Inc., Bannockburn, IL, USA) after a 5-min rest. The average of three separate 
recordings is reported. WC was measured on bare skin, at the top of the iliac crest to the 
nearest 0.1 cm. The average of 3 separate recordings is reported. Subjects were 
responsible for recording all food and beverages consumed, for two non-consecutive 
weekdays and one weekend day. Dietary intake was analyzed using Nutrition Data 
System for Research (NDSR) 2014 (Nutrition Coordinating Center, University of 
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Minnesota) to quantify macronutrient, micronutrient and carotenoid intake, glycemic 
index, and glycemic load.  
2.5. Plasma Lipids, Glucose, and Liver Enzymes 
Fasting plasma samples from the end of each intervention period were analyzed for 
TC, HDL-C, TG, GLU, alanine aminotransferase (ALT), and aspartate aminotransferase 
(AST) levels. Samples were measured using an automated clinical chemistry analyzer 
(Cobas c111, Roche Diagnostics, Indianapolis, IN, USA), LDL-C was estimated using the 
Friedewald equation [28]. 
2.6. Measures of Satiety 
Satiety was analyzed by subjective (satiety visual analog (VAS) scales) and objective 
(plasma ghrelin) measurements. Participants completed corresponding VAS on the same 
days as the three-day dietary intake records [15]. Satiety scales were completed prior to 
breakfast, lunch and dinner. Each VAS questionnaire was composed of eight open-ended 
questions regarding hunger, satisfaction, fullness, satiety and taste preference for savory, 
salty, sweet, or fatty foods. The VAS was a 10-cm line, ranging from “not at all” to “yes 
very much.” Participants marked along the line indicating their feelings, which was then 
assigned a quantifiable value by measuring from the beginning of the line to where the 
participant had marked. Values were recorded to the tenth position for analysis. To 
measure ghrelin, fasting plasma from the end of each intervention period was acidified 
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with 1 M hydrochloric acid to retain stability at −80 °C. Total ghrelin was quantified using 
a sandwich ELISA kit, (Mercodia AB, Uppsala, Sweden). 
2.7. Statistical Analysis 
All statistical analyses were performed using SPSS version 22. Paired t-tests were 
used to assess differences between dietary treatments and baseline values were used 
as a covariate. Data are reported as mean ± SD unless noted otherwise. p < 0.05 was 
considered significant.  
Results 
3.1. Study Flow Chart  
Of the 55 potential participants screened, five were excluded due to a personal 
decision not to participate. During the first phase of the study, two participants dropped 
out due to failed compliance while consuming oatmeal; 48 participants completed the 
study (Figure 3.1).  
3.2. Baseline Characteristics 
Characteristics of participants at baseline are shown in Table 4.1. The average age 
of participants was 23.3 years with a distribution of 26 females and 24 males. Baseline 
anthropometrics were within healthy ranges, with an average BMI of 23.2, a WC of 81.3 
and an average BP of 112/72 mmHg. Participants had a healthy lipid profile, with average 
TC < 3.9 mmol/L, LDL-C < 1.9 mmol/L, TG < 0.8 mmol/L, and HDL > 1.7 mmol/L. The 
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average fasting GLU < 5.1 mmol/L and C-reactive protein (CRP) of 0.2 mg/L indicated no 
significant glucose sensitivity or inflammation, respectively, at baseline. 
3.3. Dietary Intake 
While there was no significant difference in energy intake between treatment periods, 
following the EGGS period, the percentage of calories from protein and fat increased (p 
< 0.001), while the percentage of calories from carbohydrates decreased (p < 0.001), 
(Table 4.2). The intake of both saturated fatty acids (SFA) and monounsaturated fatty 
acids (MUFA) was increased with egg consumption (p < 0.001), while there was no 
difference in the intake of polyunsaturated fatty acids (PUFA) between treatment groups. 
As expected, the dietary cholesterol intake was increased during the EGGS period (p < 
0.001). Comparatively, the total and soluble fiber intake was significantly increased during 
the OATS period (p < 0.05). Despite egg yolks serving as a bioavailable source of lutein 
and zeaxanthin [29], there was no difference in the dietary intake of the carotenoids lutein 
and zeaxanthin between the EGGS and OATS periods. Similarly, no changes in the 
glycemic index were observed between treatments, whereas the glycemic load was 
decreased during the EGGS period (p < 0.05) (Table 4.2).  
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Table 4.1. Baseline characteristics of subjects 1. 
Parameter Values 
Age (years) 23.3 ± 3.1 
Gender (n = F/M) 26/24 
BMI (kg/m2) 23.2 ± 2.1 
WC (cm) 81.3 ± 6.5 
Systolic BP (mmHg) 112.1 ± 12.4 
Diastolic BP (mmHg) 72.7 ± 7.0 
Total Cholesterol (mmol/L) 3.9 ± 0.7 
LDL-C (mmol/L) 1.9 ± 0.6 
HDL-C (mmol/L) 1.7 ± 0.5 
LDL-C/HDL-C 1.2 ± 0.07 
Triglycerides (mmol/L) 0.9 ± 0.04 
Glucose (mmol/L) 5.1 ± 0.3 
CRP (mg/dL) 0.2 ± 0.8 
1 Values are presented as mean ± SD; n = 50. 
3.4. Anthropometrics, Blood Pressure, Plasma Lipids, Glucose, and Liver Enzymes  
There were no differences in the anthropometric measures of WC, BMI, and systolic 
or diastolic BP between the two breakfasts. Following egg intake there was an increase 
in TC, LDL-C, and HDL-C (p < 0.05), with no change in the LDL-C/HDL-C ratio. There 
were no significant differences in TG, GLU, ALT or AST when participants were 
consuming eggs or oatmeal for breakfast (Table 4.3).  
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Table 4.2. Dietary intake during eggs and oatmeal periods 1. 
Parameter Eggs Oatmeal 
Weight (kg) 68.2 ± 11.2 68.2 ± 11.1 
Energy (Kcal) 1937 ± 630 2016 ± 1461 
Protein (%) 19.2 ± 4.4 17.6 ± 4.1 
Carbohydrate (%) 41.4 ± 6.2 ** 48.9 ± 8.2 
Total Fat (%) 37.2 ± 5.1 ** 32.2 ± 6.7 
SFA (g/day) 27.3 ± 11.9 ** 21.1 ± 8.1 
MUFA (g/day) 30.4 ± 11.6 ** 23.2 ± 9.6 
PUFA (g/day) 16.6 ± 7.4 15.7 ± 11.5 
Total Fiber (g/day) 18.3 ± 7.0 20.9 ± 11.4 
Soluble Fiber (g/day) 5.6 ± 2.6 * 7.0 ± 4.0 
Insoluble Fiber (g/day) 12.7 ± 7.4 13.9 ± 8.0 
Cholesterol (mg/day) 546.1 ± 96.6 ** 173.1 ± 90.6 
Lutein + Zeaxanthin (µg/day) 2820 ± 3443 2327 ± 3997 
Glycemic Index 59.0 ± 5.9 59.9 ± 6.0 
Glycemic Load 109.9 ± 42.4 * 122.6 ± 49.1 
1 Values are presented as mean ± SD; n = 48; * p < 0.025, ** p < 0.001. 
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Table 4.3. Anthropometrics, blood pressure, plasma lipids, glucose, and liver 
enzymes after the eggs and oatmeal breakfasts 1. 
Parameter  Eggs Oatmeal 
BMI (kg/m2) 23.2 ± 2.2 22.7 ± 2.6 
WC (cm) 81.9 ± 6.4 82.6 ± 6.6 
Systolic BP (mmHg) 110.3 ± 10.1 111.2 ± 11.7 
Diastolic BP (mmHg) 74.4 ± 6.4 73.4 ± 6.3 
Total cholesterol (mmol/L) 4.2 ± 0.7 * 4.0 ± 0.7 
LDL cholesterol (mmol/L) 2.1 ± 0.7 * 1.9 ± 0.6 
HDL cholesterol (mmol/L) 1.71 ± 0.48 * 1.62 ± 0.47 
LDL-C/HDL-C 1.35 ± 0.62 1.30 ± 0.56 
Triglycerides (mmol/L) 0.89 ± 0.37 0.91 ± 0.41 
Glucose (mmol/L) 5.1 ± 0.4 5.0 ± 0.4 
ALT (U/L) 18.2 ± 7.9 17.6 ± 6.0 
AST (U/L) 24.5 ± 7.8 24.5 ± 8.8 
1 Values are presented as mean ± SD; n = 48; * p < 0.025. 
3.5. Measurements of Satiety: VAS and Plasma Ghrelin 
The analysis of VAS revealed that participants consuming eggs for breakfast felt more 
satisfied prior to consuming dinner than participants consuming oatmeal, suggesting a 
prolonged effect of egg intake on satiety throughout the day (Figure 4.1a). Participants 
consuming eggs felt more of a desire to consume something sweet for breakfast, then 
less of a desire for something sweet prior to lunch and dinner (Figure 4.1b). Finally, 
participants consuming eggs felt less of a desire to consume something salty or savory 
for breakfast, as compared to participants consuming oatmeal for breakfast (Figure 
4.1c,d).  
	
	
	
85	
Figure 4.1. Results from satiety VAS completed prior to each meal during OATS (white 
bars) and EGGS (black bars) periods; n = 48. (a) Participants consuming two eggs per 
day felt more satisfied prior to eating dinner; (b) Participants consuming two eggs per day 
wanted something sweet for breakfast as compared to lunch and dinner; (c) Participants 
consuming two eggs did not prefer something salty as compared to oatmeal; (d) 
Participants wanted something less savory following the consumption of two eggs per 
day; * different from oatmeal at p < 0.05 and ** different from oatmeal at p < 0.01. 
 
We further aimed to examine an objective measure of satiety. Following four weeks 
of eggs consumption for breakfast, fasting plasma ghrelin was significantly decreased, by 
4.3% as compared to an oatmeal breakfast, indicating less feelings of hunger upon 
waking as compared to an oatmeal breakfast (Figure 4.2). A negative correlation was 
identified between ghrelin and BMI, indicating an association between the biological 
indication of hunger and body weight (Figure 4.3). 
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Figure 4.2. Fasting plasma ghrelin concentrations for subjects after the oatmeal (577.8 ± 
219.7 pg/mL) and eggs (553.0 ± 181.5 pg/mL) periods, * p < 0.05. Participants (n = 48) 
had lower circulating total ghrelin following consumption of two eggs. 
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Figure 4.3. Correlation between fasting plasma ghrelin and body mass index (BMI) 
following the consumption of two eggs for breakfast; participants (n = 48), r = −0.47, p < 
0.01. 
Discussion 
Despite the recent removal of the dietary cholesterol intake limit [30], habitual egg 
consumption remains controversial and misunderstood by the general public. Therefore, 
the purpose of this study was to determine whether an egg-based breakfast as compared 
to a certified heart-healthy breakfast of oatmeal would increase the biomarkers 
associated with CVD risk and affect appetite in a young, healthy population. Although 
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there was an increase in both LDL-C and HDL-C, we found the consumption of two eggs 
per day as compared to an oatmeal breakfast did not increase the LDL-C/HDL-C ratio, 
while increasing satiety as measured by fasting plasma ghrelin and VAS.  
The impact of dietary cholesterol on plasma lipids varies among individuals, 
potentially due to variations in the negative feedback regulation of endogenous 
cholesterol production in response to cholesterol intake [31]. In this study, the 
consumption of two eggs per day did raise TC levels, corresponding to the increased 
intake of dietary cholesterol as compared to oatmeal. Notably, egg-induced increases in 
TC are related to concurrent increases in both LDL-C and HDL-C, which has been 
observed in previous egg studies [12,32,33]. The maintenance of the LDL-C/HDL-C ratio, 
an accepted CVD prediction model, does not impact CVD risk, which, in contrast to 
previous epidemiological studies that associated egg consumption with increased LDL-C 
only, then extrapolated that data to an increased risk of CVD with egg intake [34].  
This concurrent increase in HDL-C may be suggestive of improved reverse 
cholesterol transport (RCT) because it is indicative of greater amounts of cholesterol 
being removed from the tissues [35]. It is hypothesized that the phospholipids from eggs 
are involved in this modulation of RCT by impacting the HDL size and function, as well as 
the expression of hepatic HDL uptake receptors [36]. In a human clinical trial, ex vivo 
cholesterol efflux, the critical first step of RCT, was found to be increased following egg 
consumption [37]. Two large meta-analyses have reported no association between 
regular egg consumption and the risk of CVD, myocardial infarction or stroke in the 
general population [38,39]. Thus, although TC, LDL-C and HDL-C levels were increased 
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following egg consumption, regulatory mechanisms may have compensated for the 
added dietary cholesterol and biomarkers of CVD risk remained unchanged in this 
population. 
Our results reported the increased consumption of protein and fat throughout the day, 
with no impact on the total energy intake or change in body weight following the 
consumption of two eggs at breakfast. High-protein diets have been found to increase 
energy expenditure, and promote a negative energy balance [17]. In a study in healthy 
individuals who consumed low- or high-protein diets, with sustained carbohydrate 
consumption (50%), researchers found a decrease in appetite and caloric intake with 
high-protein intake. In our study, a decrease in hunger and an increase in fullness were 
seen between weeks 3 and 4 of the isocaloric high-protein diet; however, a decrease in 
caloric intake was sustained for the ad libitum high-protein leg of the study. This correlated 
with increased plasma ghrelin over time. Although this study did not reduce the amount 
of carbohydrates in the diet, we found similar results to a high-protein diet with a 
decreased carbohydrate intake as well [18]. The glycemic load is an accurate measure 
of the degree to which carbohydrate-containing foods will affect plasma glucose levels 
[40]. Reductions in glycemic load have previously been associated with carbohydrate-
restricted diets and egg consumption [41]. The reduction in carbohydrates following the 
consumption of eggs is the likely cause of the reduction in the glycemic load, which has 
been implicated in the control of glucose and lipid metabolism [42].  
Protein increases satiety and thus may explain the decrease in ghrelin levels. In a 
study investigating the effect of protein intake on the plasma ghrelin concentration, there 
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was a significant reduction in ghrelin over time when consuming higher-protein diets 
compared to carbohydrate diets [18]. A study in children and adolescents evaluated 
satiety at lunchtime following either an egg or bagel breakfast [47]. There were no 
significant differences in dietary intake at lunchtime in either group, according to dietary 
intake analysis and VAS. However, the peptide YY (PYY) was increased following egg 
consumption, which is also suggestive of increased satiety. This increase was observed 
often after consuming foods higher in protein and fat. The authors attributed the lack of 
correlation between dietary consumption and ghrelin levels to the children’s ability to self-
regulate food intake better than adolescents and adults [43]. Conversely, a study 
investigating the impact of macronutrient intake on levels of cortisol, which stimulates 
food intake, found decreased levels throughout the day following the intake of protein and 
fat as compared to carbohydrates [44]. Equally, the intake of carbohydrates for breakfast 
caused an increase in the cortisol concentration, which may be related to increased 
feelings of hunger throughout the day. Eating comfort food, high in sugar, is proposed to 
cause stress that further increases cortisol concentrations throughout the day [44]. 
Ghrelin is down-regulated in positive energy balance, and up-regulated in negative 
energy balance, in healthy-weight individuals [45]. Tschop et al. [46,47] also reported a 
negative correlation between fasting ghrelin and percent body fat. In our study, we found 
similar results, with those individuals with higher BMIs having the lowest plasma ghrelin. 
This can be attributed to a negative feedback mechanism, in which the body is attempting 
to maintain energy balance homeostasis and the regulation of feeding [48].  
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Following egg consumption, we likewise observed decreased circulating ghrelin. This 
may be related to the increased protein intake as a result of egg intake. Egg protein has 
the highest biological value of any other protein at an 88–95/100 rating, indicating the 
presence of all amino acids, both dispensable and indispensable. High-biological-value 
proteins have been suggested to delay gastric emptying and to have a stronger effect on 
decreasing post-prandial ghrelin concentrations [24]. Ghrelin also follows a diurnal 
pattern, dipping around 2 p.m. and steadily increasing as the night continues, which can 
be implicated in hunger upon waking [46]. From comparing our results, in which we 
observed decreased plasma ghrelin and increased satisfaction at dinnertime with egg 
consumption, we can hypothesize that eggs play a long-term role in satiety. In a study 
investigating the effect of protein intake on plasma ghrelin concentrations, there was a 
significant reduction in ghrelin over time when consuming higher-protein diets as 
compared to carbohydrate diets [49]. This may be due to the satiating effects of protein 
and the impact of easy digestion. In the case of egg consumption, the high biological 
value helps with the digestibility and improved satisfaction at dinnertime compared to the 
oatmeal breakfast [50].  
There are several limitations to this study including the use of whole foods for the 
intervention, which does not allow the participants to be blinded to the specific breakfast. 
However, any bias over the foods consumed was removed since no expectations of the 
data were shared with the participants. Another limitation would be ghrelin measurement, 
which was assessed prior to consuming breakfast only. The post-prandial assessment of 
ghrelin would have strengthened the results found by VAS analysis. While appetite was 
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affected following the consumption of eggs, there were no observed differences in energy 
intake. This could be considered a limitation, because though satiety was improved, this 
may not be considered an effective treatment for weight loss. There were also some 
strengths to this study including the use of whole foods, as the results can be easily 
extrapolated to the general population, because these foods are normally consumed for 
breakfast. The assessment of satiety via VAS and the plasma measurement of ghrelin 
were also strengths of this study in evaluating and correlating hunger and the desire to 
eat throughout the day. 
The intake of two eggs per day as compared to an oatmeal breakfast promoted a shift 
in dietary intake patterns, did not lead to an increase in biomarkers associated with CVD, 
and resulted in both subjective and objective measures of satiety in a healthy population. 
The results of the study are important to confirming eggs as a healthy habitual breakfast 
food with additional benefits of increased satiety throughout the day. 
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Chapter 5 
 
Consumption of two eggs per day 
increased large HDL and LDL particle 
concentrations and presence of carotenoids 
while maintaining plasma TMAO levels and 
decreasing TNF-alpha concentrations  
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Abstract: Habitual consumption of eggs has been hypothesized to positively modify 
biomarkers of CVD risk through proposed anti-inflammatory and antioxidant properties. 
To examine this relationship, fifty young, healthy men and women were enrolled into a 
randomized crossover clinical intervention. Participants consumed either two eggs per 
day or one packet of oatmeal a day for four weeks, followed by a three-week wash-out 
and cross-over to the alternate breakfast. Three-day dietary records, fasting blood 
samples and peripheral blood mononuclear cells (PBMC) were collected at the end of 
each intervention period. Increases in large HDL and large LDL particle concentrations 
as measured by NMR was found following egg consumption (p < 0.001, p < 0.05), 
respectively, with increased apoAI concentration (p < 0.05). While there was no difference 
in the intake of antioxidants lutein and zeaxanthin, a significant increase in plasma 
concentrations of these carotenoids was observed (p < 0.001). There was no change in 
LCAT, CETP, PON-1 between breakfast interventions. Intake of dietary and choline 
plasma choline was increased following egg consumption (p < 0.001), however, there 
was no change in plasma trimethylamine N-oxide (TMAO) levels. Gene expression 
results showed no impact of two eggs per day on genes related to cholesterol metabolism, 
oxidation and TMAO production. These results suggest the consumption of two eggs for 
breakfast provides increased antioxidant presence, lipoprotein modulation, ability lower 
inflammation and improve biomarkers of CVD risk while not affecting TMAO levels in this 
population. 
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1. Introduction 
 There is a well-known inverse relationship between plasma high-density 
lipoprotein cholesterol (HDL-C) levels and cardiovascular disease (CVD) (1). The primary 
mechanism for this relationship is the role of HDL in reverse cholesterol transport (RCT) 
and CVD protection (2). RCT is a process where excess cholesterol is effluxed out of cells 
to HDL, and then transported back to the liver for excretion (3). The HDL-mediated efflux 
from cholesterol-laden macrophages is particularly important in the prevention of 
atherosclerosis, or the deposition of excess lipids into artery walls (4). Beyond RCT, HDL 
has been proposed to have various other functions including anti-inflammatory, 
antioxidant, antithrombotic and antimicrobial properties (5). Though interaction with 
various proteins, over 100 have been identified, HDL functionality can span beyond RCT 
to protect against CVD and other health related complications (6).  
 Specific proteins involved in HDL metabolism and RCT such as lecithin:cholesterol 
acyl transferase (LCAT), cholesterol ester transfer protein (CETP), apolipoprotein AI 
(apoAI) and paraoxonase-1 (PON1) have been linked to HDL functionality (7). These 
proteins have been suggested to have a role in HDL remodeling, cholesterol efflux and 
antioxidant activity (8). The ability for HDL to be remodeled in circulation has been an 
area of interest, as current literature is still uncertain about the most effective species of 
for HDL particles. Currently, it is hypothesized that larger HDL particles will be able to 
transport more cholesterol for excretion, as well as have a larger surface area to carry 
	
	
	
102	
beneficial proteins (9). The role of HDL as an antioxidant is relevant to the ability to 
prevent and reverse CVD (10).  
Increased circulation of HDL-C via egg consumption has been suggested to be a 
marker of increased RCT and have potential in reducing risk of atherosclerosis 
development (11). Studies have shown the ability of eggs to increase HDL concentration 
in circulation, which may improve RCT, by the proposed ability to carry more cholesterol 
to the liver for excretion (12–14). Egg phospholipids (PL) have been shown to play a role 
in the ability of HDL to accept excess cholesterol from cells during the early stages of 
RCT (15). Specifically, PL from eggs, have been observed to be preferentially 
incorporated into HDL particles, which have a postulated role in beneficial remodeling of 
HDL (15,16). Additionally, whole eggs consumption has been associated with the 
upregulation of genes associated with RCT, such as cholesterol efflux transporters, ATP-
binding cassette transporter A1 (ABCA1) and ATP-binding cassette transporter G1 
(ABCG1) and HDL receptor, Scavenger Receptor class B type 1 (SR-BI), which removes 
HDL in the liver is suggested to target the removed cholesterol for excretion (17).  
Nutritionally, eggs are the highest quality protein available in a single food source 
and also contain: essential vitamins & minerals, antioxidant carotenoids lutein and 
zeaxanthin, lecithin, choline, cholesterol and PL (18,19). Previous studies have 
associated habitual egg consumption with decreased energy intake, increased satiety, 
and weight loss in certain populations (20,21). High quality protein or complete protein 
contains all indispensable and dispensable amino acids and are easily and highly 
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digestible (19). Protein can increase satiety or the feeling of fullness, as well as increase 
energy expenditure (22).  
While egg consumption has been met with controversy, this issue has been 
challenged by numerous studies in our laboratory demonstrating the lack of increased 
risk of CVD with dietary cholesterol consumption and additional beneficial effects of daily 
whole egg intake (13,23,24). Whole egg consumption studies have resulted in lack of 
increase in the biomarkers associated with CVD risk and improvement in the markers of 
chronic inflammation, glucose intolerance, and insulin resistance in several distinct 
populations: children, individuals with metabolic syndrome and individuals with type 2 
diabetes (12,14,25). Additionally, due to recent evidence linking trimethylamine N-oxide 
(TMAO) levels to CVD, eggs have become an area of interest again as they are a rich 
source of choline in the diet (26). Choline is metabolized by gut microbiota to form 
trimethylamine (TMA), which is then oxidized by flavin-containing monooxygenases 
(FMOs) into TMAO (27). However, due to the proposed antioxidant capacity of egg 
consumption and enhanced HDL functionality, we hypothesize no change in TMAO levels 
with the consumption of two eggs for breakfast. Furthermore, to understand the effect of 
egg consumption on HDL functionality, we hypothesized that the consumption of two eggs 
per day, as compared to an oatmeal breakfast would promote favorable changes to the 
HDL profile, increase antioxidant activity without negatively affecting TMAO levels or CVD 
risk. 
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2. Materials and Methods 
2.1 Experimental Design 
The participant population for this study was young, healthy men and women 
between the ages of 18 and 30 years with a body mass index (BMI) ³ 18.5 and £ 30 
kg/m2, blood pressure <140/90 mmHg, fasting triglycerides <500 mg/dL, fasting glucose 
<126 mg/dL, or fasting total cholesterol <240 mg/dL. Fifty participants were recruited, to 
allow for attrition, based on the standard deviation from our previous studies and using a 
Z value of 1.96 (95% confidence interval) to detect differences in HDL-C between groups 
(12,14). Previous data has resulted in significant differences between egg and egg 
substitute groups using a crossover design with 40 participants (24). The study was a 
crossover design where participants were randomly allocated to consume either 2 eggs 
(EGGS) per day or 1 packet of oatmeal (OATS) per day for breakfast for 4 weeks each. 
There was a 3-week washout in between the intervention periods where participants did 
not consume eggs or oatmeal. Subjects were allowed to consume eggs and oatmeal as 
desired, and daily compliance was monitored by self-report. Following each intervention 
period participants completed 3-day dietary and exercise records and fasting blood 
samples were collected as described (28). Dietary intake was analyzed using Nutrition 
Data System for Research (NDSR) 2014 (Nutrition Coordinating Center, University of 
Minnesota) to quantify carotenoid and choline intake. This study was approved by the 
Institution Review Board at the University of Connecticut (protocol #H14-032). This trial 
is registered at ClinicalTrials.gov as NCT02181244.   
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2.2 Lipoprotein Particle Size 
Fasting plasma was analyzed following eggs or oatmeal consumption to determine 
total lipoprotein particle number, size and concentration using Nuclear Magnetic 
Resonance (NMR). This technique provides information on individual lipoprotein particle 
subfraction by counting the number of lipoprotein particles available in a sample. NMR 
spectroscopy uses short pulses of radio frequency energy within a strong magnetic field, 
to identify and quantify concentrations of lipoproteins in plasma (12). The amplitude of the 
NMR signal was measured, which is directly proportional to the concentration of the 
particles, which can then be separated the signals into distinct subclasses. NMR 
simultaneously quantifies >30 lipoprotein fractions that are grouped into 10 subclasses 
based on diameter: large VLDL (>60 nm), medium VLDL (35–60 nm), small VLDL (27–
35 nm), IDL (23–27 nm), large LDL (21.2–23 nm), medium LDL (19.8–21.2 nm), small 
LDL (18–19.8 nm), large HDL (8.8–13 nm), medium HDL (8.2–8.8 nm) and small HDL 
(7.3– 8.2 nm). Analysis was performed by LipoScience, Inc. 
2.3 Plasma Apolipoproteins 
Plasma apolipoproteins (A-I, A-II, B100, C-II, C-III, E) were quantified using a 
commercially available human apolipoprotein multiplex assay kit (EMD Millipore) and 
analyzed by Luminex MAGPIX analyzer (Luminex Corporation. This procedure quantifies 
apolipoproteins in plasma using antibody-immobilized fluorescent dye-labeled 
microspheres. The intra-assay variability is less than 5% for plasma apolipoproteins (12).  
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2.4 LCAT, CETP, PON1 and Inflammatory Markers  
LCAT and CETP activities were measured using commercially available specific 
activity kits. LCAT activity was measured following incubation with fluorescently labeled 
substrate, with strength of fluorescence signal over time indicating relative activity (Cell 
Biolabs, Inc.) CETP activity was determined from fasting plasma by measuring the 
transfer of a fluorescent neutral lipid from a donor to acceptor molecule (BioVision, Inc). 
The mediated fluorescence was measured by microplate reader (BioTek Intstruments). 
The intra-assay variability for both assays was < 5%.  
PON1 arylsesterase activity was measured using spectrophotometric methods as 
previously described (29). This is a measure of PON1 activity toward phenyl acetate in 
fasting serum, with an intra-assay variability of 4%. Tumor Necrosis Factor alpha (TNFa) 
and Interleukin-6 (IL-6) were measured using commercially available enzyme linked 
immunosorbent assay (ELISA) kits. The sandwich immunoassay measures presence of 
cytokines using an antibody coated plate to capture and quantify protein in plasma 
(Abcam, Inc). Protein is quantified by signal strength that is proportional to the amount of 
bound analyte at intensity (450-600 nm). C Reactive Protein (CRP) was measured using 
an automated clinical chemistry analyzer (Cobas c111, Roche Diagnostics). 
2.5 Plasma Carotenoids and TMAO 
Plasma carotenoids, lutein and zeaxanthin were extracted from plasma using a 2:1 
chloroform:methanol, 0.85% NaCl, unfiltered hexane, and carotenoid internal standard 
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(trans-b-apo-8’-carotenal, Sigma-Aldrich). Analysis of samples was done using high 
performance liquid chromatography (HPLC) on Shimadzu Prominence UFLC (Shimadzu 
Corporation), C30 3 mm 150x4.6mm carotenoid column (YMC America) and guard 
column. Internal standard trans-b-apo-8’-carotenal, (Sigma-Aldrich) and external 
standards of purified lutein and zeaxanthin (Sigma-Aldrich) were used to determine a 
standard curve for carotenoid recovery efficiency. Plasma TMAO was measured by liquid 
chromatography coupled with tandem mass spectrometry (LC-MS/MS) as previously 
described (30). 
2.7 Gene Expression 
Peripheral blood mononuclear cell (PBMC) isolation was carried out following each 
breakfast intervention period. Fasting blood (40 mL) was collected from subjects into 
EDTA vacutainer tubes and kept on ice. Blood was diluted with 10 mL sterile 10X 
phosphate-buffered saline (PBS) and mixed gently. Blood was layer over Histopaque 
solution and centrifuged at 400 x g for 35 minutes using a Beckman Coulter centrifuge 
with a swing-bucket rotor to separate the PBMC buffy coat. Buffy coats were collected 
and diluted with PBS, washed twice and re-suspended in RPMI medium. For storage, 
samples were diluted 1:1 with cryopreservation media (RPMI containing 20% fetal bovine 
serum, 10% dimethyl sulfoxide) and frozen at a controlled rate in CoolCell containers 
(BioCision, LLC) at -80°C for at least 24 hrs. PBMC samples were then transferred to 
liquid nitrogen for long-term storage. 
	
	
	
108	
  PBMC messenger RNA (mRNA) expression of genes related to cholesterol 
metabolism, oxidation and TMAO production were determined using quantitative real-
time RT-PCR (qRT-PCR). RNA was extracted from freshly isolated PBMCs using TRIzol 
reagent (Invitrogen, Inc) according to the manufacturer’s instructions and using methods 
previously described (31). Synthesis of complementary DNA (cDNA) was performed as 
previously described and Bio-Rad C1000 Thermal Cycler (Bio-Rad Laboratories, Inc) 
(29). Gene expression was measured using iTaq Universal SYBR Green Supermix (Bio-
Rad Laboratories, Inc) procedure with qRT-PCR analysis. Primer sequences were  
 designed according to the GenBank database (Table 5.1). Expression levels of each 
target gene were calculated from threshold cycle (Ct) values, converted to relative 
expression using the comparative 2-ΔΔCt method, and normalized to GAPDH mRNA 
expression.  
 Table 5.1. Quantitative real-time RT-PCR primer sequences 
 HMGCR (HMG-CoA reductase), LDLr (low-density lipoprotein receptor), CD36 (cluster 
determinant 36), SRA (scavenger Receptor A), FMO3 (flavin monooxygenase 3), GAPDH 
(Glyceraldehyde 3-phosphate dehydrogenase) 
Gene Forward Primer Reverse Primer 
HMGCR 5’- CCCAGTTGTGCGTCTTCCA-3’ 5’- TTCGAGCCAGGCTTTCACTT-3’ 
LDLR 5’- ACTGGGTTGACTCCAAACTTCAC-3’ 5’- GGTTGCCCCCGTTGACA -3’ 
CD36 5’- GGCTGTGACCGGAACTGTG -3’  
5’-AGGTCTCCAACTGGCATTAGAA-3’ 
 
SRA 5’- AAAGCTATGTACCTACACACCGT -3’  
5’- CCGCCGTTTGTGACATGGA -3’ 
 
FMO3 
 
5’- TGTGGGCATCAATGGATTTGG -3’ 
 
5’- CTGGTTCTTTATAGTCCCTGCTG -3’ 
 
GAPDH 5’- TGTGGGCATCAATGGATTTGG -3’ 
 
5’- ACACCATGTATTCCGGGTCAAT -3’ 
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2.8 Statistical Analysis  
 All statistical analysis was performed using SPSS version 22, all data is reported 
± standard deviation (SD) unless noted otherwise, and significance was set at p < 0.05. 
Paired t-tests were used to assess differences between dietary treatments. 
3. Results 
3.1 Lipoprotein Particle Size 
Following the consumption of two eggs per day, TC, HDL-C, and LDL-C were 
increased in plasma (p < 0.05) as previously reported (28). In agreement with changes in 
plasma cholesterol concentrations, lipoprotein particle concentrations and size were also 
modified (Figure 5.1). While HDL size was not significantly different between the two 
breakfast interventions (p=0.06), there were significant changes when determining 
particle concentration in plasma. Following egg consumption, total HDL was not different 
between treatment groups (p=0.12), as opposed to increased HDL-C, but there was 
significant increase in the concentration of large HDL particle number. No change was 
seen in medium HDL or small HDL (p=0.07) particle concentration between treatments, 
indicating a shift toward a larger, more cholesterol rich HDL particle (Figure 5.1A). Total 
LDL particle concentration was increased as well as large LDL, while small LDL, which is 
	
	
	
110	
considered to be the particle most susceptible to oxidation remained unchanged between 
the two interventions (p=0.07) (Figure 5.1B).  
Figure 5.1. HDL (A) and LDL (B) lipoprotein particle concentration following consumption 
of two eggs or one packet of oatmeal for breakfast. Data are represented as mean ± SD; 
n=48 *p < 0.05, *** p < 0.001.  
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3.2 Plasma Apolipoproteins, LCAT, CETP, PON1 and inflammatory Markers 
Apolipoprotein concentration was assessed with no significant differences found 
in apo AII, B100, CII, CIII or E with either breakfast. Although, an increase in apoAI was 
observed following the consumption of two eggs, which suggests a relationship with 
increased HDL-C and large HDL particle size, respectively (Table 5.2) (32). No 
differences in plasma enzymes, LCAT or CETP activities were observed between the two 
different breakfasts. Surprisingly, no difference in PON1 activity was found, as this has 
been shown to increase with HDL-C and particle concentration (Table 5.2) (33). Following 
egg consumption, inflammatory cytokine TNFa was decreased, while there was no 
change in inflammatory markers CRP and IL-6.  
Table 5.2. Plasma Apolipoproteins, LCAT, CETP, PON1 and Inflammatory Markers 
After Consuming Two Eggs Compared to an Oatmeal Breakfast1 
 1Values are presented as mean ± SD; n = 48; *p < 0.05 
 
  
Parameter Eggs Oatmeal 
Apolipoprotein AI (mg/mL) 1.437 ± 0.46* 1.357 ± 0.44 
Apolipoprotein AII (mg/mL) 0.590 ± 0.12 0.580 ± 0.12 
Apolipoprotein B100 (mg/mL) 0.178 ± 0.07 0.168 ± 0.08 
Apolipoprotein CII (mg/mL) 0.242 ± 0.09 0.231 ± 0.09 
Apolipoprotein CIII (mg/mL) 0.462 ± 0.15 0.435 ± 0.14 
Apolipoprotein E (mg/mL) 0.074 ± 0.03 0.071 ± 0.03 
PON1 (kU/L) 92.08 ± 21.29 93.56 ± 20.01 
LCAT (RFU) 200.59 ± 26.58 205.63 ± 28.80 
CETP (pmol/L•h-1) 6.43 ± 12.19 6.46 ± 11.09 
CRP (mg/dL) 0.14 ± 0.22 0.16 ± 0.42 
TNFα (pg/mL) 16.92 ± 4.4* 17.91 ± 5.5 
IL-6 (pg/mL) 8.01 ± 3.3 7.62 ± 2.7 
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3.3 Plasma Carotenoids  
The dietary intake records analysis revealed no significant difference in 
consumption between intervention breakfasts, even when two eggs were included in the 
habitual diet (Figure 5.2A). In contrast to dietary intake of carotenoids, plasma 
concentrations of lutein and zeaxanthin were significantly increased (p < 0.001) following 
egg consumption (Figure 5.2B). 
Figure 5.2. Dietary intakes (A) as compared to plasma concentrations (B) of lutein and 
zeaxanthin following the consumption of two eggs or one packet of oatmeal for breakfast. 
Data are represented as mean ± SD; n=48 *** p < 0.001. 
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3.4 Choline and TMAO Concentrations 
Eggs are a naturally high source of choline, a bioactive lipid and essential nutrient 
(34). According to dietary intake analysis, a significant increase was found following the 
consumption of two eggs per day, this finding was reflected in plasma concentrations. 
(Figure 5.3A,B). However, no difference was found in TMAO levels in plasma, despite 
the increase in dietary choline provided by eggs (Figure 5.3C). 
Figure 5.3. Dietary intake of choline (A) and plasma concentrations of TMAO (B), in a 
young, healthy population that consumed two eggs per day as compared to an oatmeal 
breakfast. Data are represented as mean ± SD; n=48 *** p < 0.001. 
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3.5 PBMC Gene Expression 
We further aimed to identify if egg consumption would alter the expression of 
genes related to cholesterol metabolism (LDLr and HMGCR), uptake of lipoprotein 
derived cholesterol and oxidation (CD36 and SRA), and formation of TMAO (FMO3). No 
differences were seen in relative mRNA expression in either phase of breakfast 
consumption, in a young, healthy population (Figure 5.4). 
Figure 5.4. Intake of two eggs per day compared to an oatmeal breakfast in a young, 
healthy population had no impact on relative mRNA expression of genes related to 
cholesterol metabolism, oxidation and TMAO production. Data are represented as mean 
± SD; n=36. 
0
2
4
6
8
10
12
14
16
18
LDLr HMGCR CD36 SRA FMO3
Re
la
tiv
e	
m
RN
A	
ex
pr
es
sio
n
EGGS
OATS
Data	are	represented	as	mean	± SD;	n=36	*	p	<	0.05
	
	
	
115	
4. Discussion 
 Habitual egg intake has been misunderstood, due to concern around safety of 
consumption and potential for benefit (35). While dietary cholesterol has been deemed a 
nutrient of non-concern by the USDA Dietary Guidelines committee, the recently 
suggested link between plasma TMAO levels and CVD have put eggs back in the spotlight 
of controversy (26,36). In order to examine the safety and benefit of consuming two eggs 
per day, they were compared to a certified heart-healthy breakfast of oatmeal.  
Lipoprotein particles have the ability to be diverse in composition and size, and 
dietary intake has been shown to have an impact on this phenomenon (9). Previous 
studies have shown the ability of egg consumption to have an impact on HDL and LDL 
particle size and number (12,23,33). In this study, we found an increase in large HDL 
particle concentration following the consumption of eggs. The larger species of HDL are 
suggested to be the more anti-atherogenic variety, due to the proposed ability to carry 
more excess cholesterol from circulation back to the liver for excretion (7). It is 
hypothesized that the added phospholipids may be driving the conversion to the large 
size HDL in circulation (23,37). Additionally, apoAI, the apolipoprotein responsible for 
initial lipidation of HDL particles was found to be increased following egg consumption. 
The increase in apoAI as combined with the larger HDL species suggests a shift to a 
more anti-atherogenic lipoprotein profile. ApoAI has also been hypothesized to have 
antioxidative properties and has been shown to reduce macrophage response to 
endotoxin stimulation (38). Previous studies utilizing the feeding of 1-3 eggs have also 
	
	
	
116	
found an increase in large HDL particle size (33). A remodeling enzyme, CETP, is 
responsible for exchanging triglycerides (TG) for cholesterol esters between apoB 
containing lipoproteins and HDL in an alternate pathway of RCT (39). According to our 
data, CETP was unchanged regardless of breakfast. Currently in the literature, there is 
mixed data on the connection of CETP to CVD risk. While impairment of CETP activity 
has been suggested as a therapeutic target to reduce formation of cholesterol rich LDL 
and TG rich HDL, results have not been clear. Therefore, the finding of no difference in 
CETP activity between eggs and oatmeal could indicated that eggs are not affecting this 
parameter involved in RCT. The increase in large HDL particle concentration may also 
be reliant on the phospholipids (PL) present in eggs. Previous studies have found egg PL 
to be preferentially incorporated into large HDL molecules, which may then enhance 
mobilization of cholesterol from cells (15,18).  
Additionally, large LDL particle concentration increased following the consumption 
of eggs. This modification, as well, is consistent with previous egg feeding studies 
(23,40,41). The larger species of LDL has been suggested to be less atherogenic, as 
studies have shown the small species of LDL is most likely to be oxidized. Small LDL 
particles are hypothesized to be more easily oxidized in the endothelium and then taken 
up by macrophages, ultimately leading to the formation of foam cells and atherosclerotic 
plaque (4).  
The activity of the enzyme LCAT, which is responsible for the esterification of 
cholesterol was unchanged between breakfast treatments. In another study where 
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participants were fed a dose-dependent increase of eggs (1,2,3) for four weeks each, an 
increase in LCAT activity was found following the consumption of three eggs (33). This 
finding suggests that the consumption of dietary cholesterol from two eggs may not have 
an impact on increasing the function of the enzyme in a healthy population. In an egg 
feeding study where three eggs were consumed in a MetS population, LCAT activity was 
increased. Authors connect LCAT activity to an increase in HDL particle size and number, 
as more dietary cholesterol is being esterified and RCT is enhanced (23). LCAT may also 
be more active in individuals classified as cholesterol hyperresponders. In a study where 
individual consumed 3 eggs/day, cholesterol hyperresponders regardless of gender had 
higher activity of LCAT, in accordance with increased RCT (42). 
PON1 is an HDL-associated enzyme with the proposed ability to protect against 
oxidative damage, inflammation, lipid peroxidation liver disease (43). No significant 
increase in PON1 was found after the consumption of two eggs per day. Low serum PON1 
levels have been found in mice after consuming an atherogenic diet, while correlated with 
a reduced capacity of HDL to prevent aortic plaque development (44). Thus, an 
unchanged PON1 is an indication of low levels of inflammation in this population. 
Additionally, there were unchanged levels of the inflammatory cytokine IL-6 and 
inflammatory marker CRP, while inflammatory cytokine TNFa was reduced following the 
consumption of two eggs per day. As CRP is an acute phase response to a rising IL-6 
concentration, results are consistent with reduced inflammation in this population (45). 
TNFa, which is also part of the acute phase response, is an activator of both NF-κB 
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(Nuclear factor kappa-light-chain-enhancer of activated B cells) and MAPK (mitogen-
activated protein kinase) pathways, which are major regulators of systemic inflammation 
(46). Since this population was young and healthy, an unchanged PON1 and reduced 
TNFa may suggest egg consumption has a relationship to maintain or reduce 
inflammatory levels. 
Another factor possibly related to the observed decreases in inflammation are the 
antioxidant carotenoids lutein and zeaxanthin. According to dietary analysis, the intake of 
carotenoids, which are found in green leafy vegetables, and in yellow foods such as egg 
yolk and corn, were unchanged regardless of breakfast treatment. However, plasma 
analysis of these carotenoids, suggests increased presence of lutein and zeaxanthin in 
plasma when delivered by eggs. HDL has been shown to carry carotenoids, which 
possess antioxidative properties (47). Both of these carotenoids are hypothesized to be 
part of the mechanism of how HDL has antioxidative effects on LDL, PL and other tissues 
by preventing oxidation and protecting tissues from oxidative stress. Studies have shown 
relationships between the carotenoids and upregulation of ABCA1 and promotion of 
cholesterol efflux (48). Lutein and zeaxanthin are distributed to most tissues, but are 
found concentrated in the eye, and have shown to be important to the prevention of age 
related macular degeneration (49). Additionally, large HDL has been proposed to have 
the ability to carry a large percentage of lutein and zeaxanthin as compared to other 
carotenoids, which may be the most relevant in preventing LDL oxidation and contributing 
	
	
	
119	
to enhanced RCT (50).  Previous studies have found increased lutein and zeaxanthin in 
plasma following the consumption of eggs (23,41,51). 
A study by Tang et al. postulated a link between increased TMAO levels and risk 
of incidence for major cardiovascular events (26). TMAO is a metabolite that is converted 
in the liver by the enzyme FMO3. Prior to this conversion, TMA is formed by gut microbiota 
from various phospholipid species, specifically as identified by this group, choline (52). 
As eggs are a rich source of choline in the diet, investigation into whether choline from 
eggs is related to plasma TMAO concentration is of interest. According to dietary analysis, 
when consuming two eggs per day participants were receiving significantly more choline 
in their diet compared to the consumption of oatmeal. The lack of difference in TMAO 
levels between breakfasts suggests that egg-specific choline may not have a direct 
impact on raising plasma TMAO levels and thus have no relation to the impact on 
cardiovascular events. As recent evidence has suggested that most Americans are 
consuming suboptimal amounts of choline, which is necessary for brain and nervous 
system function, two eggs per day are safe to consume without impact on TMAO levels 
(34).  
In order to examine the connection between HDL and cholesterol metabolism 
further, gene expression analysis was carried out in the areas of cholesterol metabolism, 
oxidation product uptake and creation of TMAO. As there was no difference in any of the 
gene data it can be concluded that compared to an oatmeal breakfast, two eggs per day 
have no negative impact on the examined parameters. Despite the addition of ~360 
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mg/chol a day from eggs, there is no impact on cholesterol metabolism, suggesting the 
amount consumed is of no relevance to a properly functioning biosynthetic pathway. 
CD36 and SRA are principal receptors for the binding and uptake of ox-LDL in 
macrophages (4). No difference in gene expression indicates lack of increased uptake, 
which may be related to the species modification toward a large HDL and LDL particle 
and away from the smaller species, which is more susceptible to oxidation. Lastly, FMO3, 
the principle enzyme for conversion of TMA to TMAO was unchanged, thus coinciding 
with the maintained TMAO levels following the consumption of two eggs per day. 
There are several limitations to this study. First, the use of a young, healthy 
population can impact the effect of anti-oxidation, as this population has little to no 
inflammation at baseline. In other studies in MetS and type 2 diabetes populations, a 
more profound impact of egg consumption on inflammation has been observed (14,31). 
Additionally, we were limited by the use of PBMC in a human population. This cell type, 
which is mainly composed of lymphocytes and monocytes are lacking necessary 
enzymes, such as those found only in the liver for complete understanding of RCT. Again, 
the young, healthy population with normal total cholesterol levels did not have an effect 
to have an impact on relative measure of gene expression for cholesterol efflux-related 
proteins ABAC1 an ABCG1. However, this study provides many strengths, such as the 
collection of dietary and biological data to create a connection between nutrient intake 
and presence in plasma. This allowed us to determine the presence and impact of choline 
on both antioxidant carotenoid and TMAO concentrations, respectively. 
	
	
	
121	
The intake of two eggs per day for breakfast compared to one packet of oatmeal 
per day increased large HDL and LDL concentration in plasma and apoAI concentration 
while having no impact on variable apolipoproteins and associated enzymes. While 
dietary consumption of lutein, zeaxanthin was not increased when the oatmeal breakfast 
was compared to the egg breakfast, presence of carotenoids was increased. Further 
increases in dietary choline and plasma choline following the egg breakfast did not impact 
TMAO levels. The consumption of two eggs per day may provide the necessary 
antioxidant capacity to lower inflammation and maintain TMAO levels, while potentially 
enhancing factors related to RCT.  
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Chapter 6 
 
Significance and future directions  
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Summary of dissertation findings 
 CVD is classified as a collection of disorders that may arise from atherosclerosis. 
Currently, the leading risk factors for development are high blood pressure, smoking and 
high LDL-C. However, lifestyle risk factors, such as obesity, physical inactivity and poor 
nutrition can increase risk at well. The modification of lifestyle risk factors includes 
improving dietary intake in an effort to reduce CVD risk. Eggs are an easily attainable, 
affordable product, composed of high quality protein, vitamins, minerals, choline and 
antioxidants. Although due to content of dietary cholesterol and previous daily intake 
limits, egg consumption has been met with uncertainty.  
 We aimed to investigate habitual egg consumption as compared to a certified heart 
healthy breakfast of oatmeal. Fifty young, healthy men and women were enrolled in a 
randomized crossover clinical intervention that compared the consumption of two eggs 
per day to one packet of oatmeal for breakfast. 
 We found increased TC, HDL-C and LDL-C following egg consumption, yet no 
change was seen in the LDL/HDL ratio, a well-accepted indicator of CVD risk. There were 
no changes in TG or GLU between treatments. This finding concluded that the extra 360 
mg/day of dietary cholesterol being consumed in eggs did not cause an increase in certain 
biomarkers CVD risk. 
 Egg consumption had a marked impact on appetite scores and plasma ghrelin. 
While there was no difference in caloric intake when consuming either breakfast, dietary 
patterns shifted to a higher consumption of protein and fat with the consumption of two 
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eggs per day. When participants were asked to evaluate several markers of satiety, 
reports of feeling more satisfied at dinner, less desire to eat something sweet at lunch 
and dinner, less desire to eat something salty for breakfast and less desire to eat 
something savory at breakfast were all decreased following egg consumption. These 
findings were reflected objectively by decreased plasma ghrelin concentration following 
the consumption of two eggs per day for breakfast.  
 When we investigated the role of habitual egg consumption, in additional CVD 
biomarkers, we found an increase in large LDL and HDL particle concentration, which 
suggests a shift to a more anti-atherogenic lipoprotein profile. There was no difference in 
apo A-II, B100, C-II, C-III or E, while apoAI, the apolipoprotein necessary for lipidation of 
HDL was increased following egg consumption. Dietary intake of carotenoids did not differ 
between the two breakfast foods, but further analysis showed a significant increase in 
plasma carotenoids following consumption of eggs. Additionally, there was no change in 
LCAT, CETP, PON1 or inflammatory markers IL-6 and CRP, although TNFa was reduced 
while consuming two eggs. Intake of choline from the diet was significantly increased 
while consuming eggs, yet no increase in plasma TMAO levels was observed. Finally, 
analysis of genes related to cholesterol metabolism, oxidation and TMAO production were 
unchanged regardless of breakfast. 
 While the dietary intake limit of cholesterol has been removed, more research is 
needed to define the beneficial role to HDL functionality and antioxidant activity that eggs 
may have. We have concluded in these findings that can be a part of a healthy diet, when 
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consumed daily, in a young, apparently healthy population, and pose no increase in 
certain biomarkers of CVD risk, improve satiety markers and may have beneficial roles to 
HDL metabolism and antioxidant presence. 
Future directions 
As dietary cholesterol has been stated as a nutrient of non-concern by the 2015-
2020 Dietary Guidelines Committee, more research is needed in populations who are still 
uncertain. Individuals with type 2 diabetes, existing CVD or who are risk for these 
diseases are populations of interest to examine the safety and benefit of egg 
consumption. More dietary interventions comparing eggs to other breakfast foods in these 
populations would help determine what the most beneficial recommendation is.  
To further the knowledge of how eggs can regulate appetite more long-term 
interventions with post-prandial sample collection would be useful. As satiety hormone 
levels are constantly changing through the day, multiple time points for collection would 
give a better idea into how eggs are effecting all day appetite regulation. Utilizing both 
objective and subjective measures in studies evaluating appetite regulation is critical, as 
regulation involves many body systems and personal choice plays a big role.  
Work needs continue to elucidate the mechanism of how egg-derived components 
have direct roles in RCT. Several components of eggs, such as PL, cholesterol, fat, 
carotenoids and choline have been suspected to enhance RCT. More long-term studies 
with feeding of three or more eggs is needed to determine if effects are modulating gene 
expression associated with cholesterol efflux in healthy populations.  
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 Finally, due to the recent finding of the relationship between dietary choline and 
TMAO levels, eggs are once again at the center of controversy. It is critical to determine 
if choline coming from eggs has a relationship to TMAO production and elucidate the 
mechanism. 
